id	sid	tid	token	lemma	pos
cord-028034-pjotppso	1	1	key	key	NNP
cord-028034-pjotppso	1	2	:	:	:
cord-028034-pjotppso	1	3	cord-028034-pjotppso	cord-028034-pjotppso	NNP
cord-028034-pjotppso	2	1	authors	author	NNS
cord-028034-pjotppso	2	2	:	:	:
cord-028034-pjotppso	2	3	Kang	Kang	NNP
cord-028034-pjotppso	2	4	,	,	,
cord-028034-pjotppso	2	5	Jian‐Sheng	Jian‐Sheng	NNP
cord-028034-pjotppso	2	6	title	title	NN
cord-028034-pjotppso	2	7	:	:	:
cord-028034-pjotppso	2	8	Vitamin	vitamin	NN
cord-028034-pjotppso	2	9	intervention	intervention	NN
cord-028034-pjotppso	2	10	for	for	IN
cord-028034-pjotppso	2	11	cytokine	cytokine	NN
cord-028034-pjotppso	2	12	storm	storm	NN
cord-028034-pjotppso	2	13	in	in	IN
cord-028034-pjotppso	2	14	the	the	DT
cord-028034-pjotppso	2	15	patients	patient	NNS
cord-028034-pjotppso	2	16	with	with	IN
cord-028034-pjotppso	2	17	coronavirus	coronavirus	NN
cord-028034-pjotppso	2	18	disease	disease	NN
cord-028034-pjotppso	2	19	2019	2019	CD
cord-028034-pjotppso	2	20	date	date	NN
cord-028034-pjotppso	2	21	:	:	:
cord-028034-pjotppso	2	22	2020	2020	CD
cord-028034-pjotppso	2	23	-	-	HYPH
cord-028034-pjotppso	2	24	06	06	CD
cord-028034-pjotppso	2	25	-	-	SYM
cord-028034-pjotppso	2	26	19	19	CD
cord-028034-pjotppso	2	27	journal	journal	NN
cord-028034-pjotppso	2	28	:	:	:
cord-028034-pjotppso	3	1	nan	nan	NNP
cord-028034-pjotppso	3	2	DOI	DOI	NNP
cord-028034-pjotppso	3	3	:	:	:
cord-028034-pjotppso	3	4	10.1002	10.1002	CD
cord-028034-pjotppso	3	5	/	/	SYM
cord-028034-pjotppso	3	6	mco2.7	mco2.7	NN
cord-028034-pjotppso	4	1	sha	sha	NNP
cord-028034-pjotppso	4	2	:	:	:
cord-028034-pjotppso	4	3	7ba2864cb445162644d5141e74665cdb3054b976	7ba2864cb445162644d5141e74665cdb3054b976	NNP
cord-028034-pjotppso	4	4	doc_id	doc_id	NNP
cord-028034-pjotppso	4	5	:	:	:
cord-028034-pjotppso	4	6	28034	28034	CD
cord-028034-pjotppso	5	1	cord_uid	cord_uid	NNS
cord-028034-pjotppso	5	2	:	:	:
cord-028034-pjotppso	5	3	pjotppso	pjotppso	NNP
cord-028034-pjotppso	5	4	nan	nan	NNP
cord-028034-pjotppso	6	1	The	the	DT
cord-028034-pjotppso	6	2	coronavirus	coronavirus	NN
cord-028034-pjotppso	6	3	disease	disease	NN
cord-028034-pjotppso	6	4	2019	2019	CD
cord-028034-pjotppso	6	5	(	(	-LRB-
cord-028034-pjotppso	6	6	COVID-19	COVID-19	NNP
cord-028034-pjotppso	6	7	)	)	-RRB-
cord-028034-pjotppso	6	8	caused	cause	VBN
cord-028034-pjotppso	6	9	by	by	IN
cord-028034-pjotppso	6	10	severe	severe	JJ
cord-028034-pjotppso	6	11	acute	acute	JJ
cord-028034-pjotppso	6	12	respiratory	respiratory	JJ
cord-028034-pjotppso	6	13	syndrome	syndrome	NN
cord-028034-pjotppso	6	14	coronavirus	coronavirus	NN
cord-028034-pjotppso	6	15	2	2	CD
cord-028034-pjotppso	7	1	(	(	-LRB-
cord-028034-pjotppso	7	2	SARS	SARS	NNP
cord-028034-pjotppso	7	3	-	-	HYPH
cord-028034-pjotppso	7	4	CoV-2	CoV-2	NNP
cord-028034-pjotppso	7	5	)	)	-RRB-
cord-028034-pjotppso	7	6	is	be	VBZ
cord-028034-pjotppso	7	7	an	an	DT
cord-028034-pjotppso	7	8	ongoing	ongoing	JJ
cord-028034-pjotppso	7	9	pandemic	pandemic	NN
cord-028034-pjotppso	7	10	.	.	.
cord-028034-pjotppso	8	1	According	accord	VBG
cord-028034-pjotppso	8	2	to	to	IN
cord-028034-pjotppso	8	3	the	the	DT
cord-028034-pjotppso	8	4	data	datum	NNS
cord-028034-pjotppso	8	5	on	on	IN
cord-028034-pjotppso	8	6	18	18	CD
cord-028034-pjotppso	8	7	April	April	NNP
cord-028034-pjotppso	8	8	2020	2020	CD
cord-028034-pjotppso	8	9	,	,	,
cord-028034-pjotppso	8	10	there	there	EX
cord-028034-pjotppso	8	11	were	be	VBD
cord-028034-pjotppso	8	12	more	more	JJR
cord-028034-pjotppso	8	13	than	than	IN
cord-028034-pjotppso	8	14	2	2	CD
cord-028034-pjotppso	8	15	million	million	CD
cord-028034-pjotppso	8	16	people	people	NNS
cord-028034-pjotppso	8	17	infected	infect	VBN
cord-028034-pjotppso	8	18	by	by	IN
cord-028034-pjotppso	8	19	SARS	SARS	NNP
cord-028034-pjotppso	8	20	-	-	HYPH
cord-028034-pjotppso	8	21	CoV-2	CoV-2	NNP
cord-028034-pjotppso	8	22	in	in	IN
cord-028034-pjotppso	8	23	211	211	CD
cord-028034-pjotppso	8	24	countries	country	NNS
cord-028034-pjotppso	8	25	and	and	CC
cord-028034-pjotppso	8	26	regions	region	NNS
cord-028034-pjotppso	8	27	,	,	,
cord-028034-pjotppso	8	28	and	and	CC
cord-028034-pjotppso	9	1	the	the	DT
cord-028034-pjotppso	9	2	mortality	mortality	NN
cord-028034-pjotppso	9	3	rate	rate	NN
cord-028034-pjotppso	9	4	of	of	IN
cord-028034-pjotppso	9	5	COVID-19	COVID-19	NNP
cord-028034-pjotppso	9	6	is	be	VBZ
cord-028034-pjotppso	9	7	about	about	RB
cord-028034-pjotppso	9	8	6.95	6.95	CD
cord-028034-pjotppso	9	9	%	%	NN
cord-028034-pjotppso	9	10	(	(	-LRB-
cord-028034-pjotppso	9	11	153	153	CD
cord-028034-pjotppso	9	12	406	406	CD
cord-028034-pjotppso	9	13	deaths	death	NNS
cord-028034-pjotppso	9	14	out	out	IN
cord-028034-pjotppso	9	15	of	of	IN
cord-028034-pjotppso	9	16	2	2	CD
cord-028034-pjotppso	9	17	205	205	CD
cord-028034-pjotppso	9	18	733	733	CD
cord-028034-pjotppso	9	19	cases	case	NNS
cord-028034-pjotppso	9	20	)	)	-RRB-
cord-028034-pjotppso	9	21	.	.	.
cord-028034-pjotppso	10	1	Two	two	CD
cord-028034-pjotppso	10	2	recent	recent	JJ
cord-028034-pjotppso	10	3	clinical	clinical	JJ
cord-028034-pjotppso	10	4	summaries	summary	NNS
cord-028034-pjotppso	10	5	of	of	IN
cord-028034-pjotppso	10	6	patients	patient	NNS
cord-028034-pjotppso	10	7	with	with	IN
cord-028034-pjotppso	10	8	COVID-19	COVID-19	NNP
cord-028034-pjotppso	10	9	reported	report	VBD
cord-028034-pjotppso	10	10	that	that	IN
cord-028034-pjotppso	10	11	cytokine	cytokine	NN
cord-028034-pjotppso	10	12	storm	storm	NN
cord-028034-pjotppso	10	13	was	be	VBD
cord-028034-pjotppso	10	14	associated	associate	VBN
cord-028034-pjotppso	10	15	with	with	IN
cord-028034-pjotppso	10	16	the	the	DT
cord-028034-pjotppso	10	17	severity	severity	NN
cord-028034-pjotppso	10	18	and	and	CC
cord-028034-pjotppso	10	19	death	death	NN
cord-028034-pjotppso	10	20	of	of	IN
cord-028034-pjotppso	10	21	patients	patient	NNS
cord-028034-pjotppso	10	22	with	with	IN
cord-028034-pjotppso	10	23	COVID-19	COVID-19	NNP
cord-028034-pjotppso	10	24	.	.	NNP
cord-028034-pjotppso	10	25	1	1	CD
cord-028034-pjotppso	10	26	,	,	,
cord-028034-pjotppso	10	27	2	2	CD
cord-028034-pjotppso	10	28	Consequently	consequently	RB
cord-028034-pjotppso	10	29	,	,	,
cord-028034-pjotppso	10	30	it	-PRON-	PRP
cord-028034-pjotppso	10	31	was	be	VBD
cord-028034-pjotppso	10	32	urgent	urgent	JJ
cord-028034-pjotppso	10	33	to	to	TO
cord-028034-pjotppso	10	34	seek	seek	VB
cord-028034-pjotppso	10	35	effective	effective	JJ
cord-028034-pjotppso	10	36	prevention	prevention	NN
cord-028034-pjotppso	10	37	and	and	CC
cord-028034-pjotppso	10	38	treatments	treatment	NNS
cord-028034-pjotppso	10	39	for	for	IN
cord-028034-pjotppso	10	40	the	the	DT
cord-028034-pjotppso	10	41	cytokine	cytokine	NN
cord-028034-pjotppso	10	42	storm	storm	NN
cord-028034-pjotppso	10	43	in	in	IN
cord-028034-pjotppso	10	44	COVID-19	covid-19	JJ
cord-028034-pjotppso	10	45	patients	patient	NNS
cord-028034-pjotppso	10	46	,	,	,
cord-028034-pjotppso	10	47	especially	especially	RB
cord-028034-pjotppso	10	48	those	those	DT
cord-028034-pjotppso	10	49	under	under	IN
cord-028034-pjotppso	10	50	intensive	intensive	JJ
cord-028034-pjotppso	10	51	care	care	NN
cord-028034-pjotppso	10	52	unit	unit	NN
cord-028034-pjotppso	10	53	(	(	-LRB-
cord-028034-pjotppso	10	54	ICU	ICU	NNP
cord-028034-pjotppso	10	55	)	)	-RRB-
cord-028034-pjotppso	10	56	.	.	.
cord-028034-pjotppso	11	1	The	the	DT
cord-028034-pjotppso	11	2	clinical	clinical	JJ
cord-028034-pjotppso	11	3	features	feature	NNS
cord-028034-pjotppso	11	4	of	of	IN
cord-028034-pjotppso	11	5	138	138	CD
cord-028034-pjotppso	11	6	patients	patient	NNS
cord-028034-pjotppso	11	7	with	with	IN
cord-028034-pjotppso	11	8	COVID-19	COVID-19	NNP
cord-028034-pjotppso	11	9	revealed	reveal	VBD
cord-028034-pjotppso	11	10	that	that	IN
cord-028034-pjotppso	11	11	the	the	DT
cord-028034-pjotppso	11	12	number	number	NN
cord-028034-pjotppso	11	13	of	of	IN
cord-028034-pjotppso	11	14	lymphocytes	lymphocyte	NNS
cord-028034-pjotppso	11	15	decreased	decrease	VBD
cord-028034-pjotppso	11	16	,	,	,
cord-028034-pjotppso	11	17	the	the	DT
cord-028034-pjotppso	11	18	number	number	NN
cord-028034-pjotppso	11	19	of	of	IN
cord-028034-pjotppso	11	20	monocytes	monocyte	NNS
cord-028034-pjotppso	11	21	unchanged	unchanged	JJ
cord-028034-pjotppso	11	22	,	,	,
cord-028034-pjotppso	11	23	and	and	CC
cord-028034-pjotppso	11	24	the	the	DT
cord-028034-pjotppso	11	25	number	number	NN
cord-028034-pjotppso	11	26	of	of	IN
cord-028034-pjotppso	11	27	neutrophil	neutrophil	NN
cord-028034-pjotppso	11	28	significantly	significantly	RB
cord-028034-pjotppso	11	29	increased	increase	VBN
cord-028034-pjotppso	11	30	,	,	,
cord-028034-pjotppso	11	31	which	which	WDT
cord-028034-pjotppso	11	32	might	may	MD
cord-028034-pjotppso	11	33	account	account	VB
cord-028034-pjotppso	11	34	for	for	IN
cord-028034-pjotppso	11	35	the	the	DT
cord-028034-pjotppso	11	36	cytokine	cytokine	NN
cord-028034-pjotppso	11	37	storm	storm	NN
cord-028034-pjotppso	11	38	.	.	.
cord-028034-pjotppso	12	1	2	2	LS
cord-028034-pjotppso	13	1	In	in	IN
cord-028034-pjotppso	13	2	addition	addition	NN
cord-028034-pjotppso	13	3	,	,	,
cord-028034-pjotppso	13	4	Guan	Guan	NNP
cord-028034-pjotppso	13	5	et	et	NNP
cord-028034-pjotppso	13	6	al	al	NNP
cord-028034-pjotppso	13	7	reported	report	VBD
cord-028034-pjotppso	13	8	that	that	IN
cord-028034-pjotppso	13	9	lymphocytopenia	lymphocytopenia	NNP
cord-028034-pjotppso	13	10	was	be	VBD
cord-028034-pjotppso	13	11	present	present	JJ
cord-028034-pjotppso	13	12	in	in	IN
cord-028034-pjotppso	13	13	83.2	83.2	CD
cord-028034-pjotppso	13	14	%	%	NN
cord-028034-pjotppso	13	15	of	of	IN
cord-028034-pjotppso	13	16	1099	1099	CD
cord-028034-pjotppso	13	17	patients	patient	NNS
cord-028034-pjotppso	13	18	with	with	IN
cord-028034-pjotppso	13	19	COVID-19	covid-19	CD
cord-028034-pjotppso	13	20	from	from	IN
cord-028034-pjotppso	13	21	552	552	CD
cord-028034-pjotppso	13	22	hospitals	hospital	NNS
cord-028034-pjotppso	13	23	in	in	IN
cord-028034-pjotppso	13	24	China	China	NNP
cord-028034-pjotppso	13	25	.	.	.
cord-028034-pjotppso	14	1	3	3	LS
cord-028034-pjotppso	15	1	Tan	Tan	NNP
cord-028034-pjotppso	15	2	et	et	FW
cord-028034-pjotppso	15	3	al	al	NNP
cord-028034-pjotppso	15	4	also	also	RB
cord-028034-pjotppso	15	5	reported	report	VBD
cord-028034-pjotppso	15	6	that	that	IN
cord-028034-pjotppso	15	7	lymphopenia	lymphopenia	NNP
cord-028034-pjotppso	15	8	predicted	predict	VBD
cord-028034-pjotppso	15	9	the	the	DT
cord-028034-pjotppso	15	10	severity	severity	NN
cord-028034-pjotppso	15	11	of	of	IN
cord-028034-pjotppso	15	12	COVID-19	COVID-19	NNP
cord-028034-pjotppso	15	13	.	.	.
cord-028034-pjotppso	16	1	4	4	LS
cord-028034-pjotppso	16	2	Overall	overall	RB
cord-028034-pjotppso	16	3	,	,	,
cord-028034-pjotppso	16	4	these	these	DT
cord-028034-pjotppso	16	5	reports	report	NNS
cord-028034-pjotppso	16	6	suggested	suggest	VBD
cord-028034-pjotppso	16	7	that	that	IN
cord-028034-pjotppso	16	8	neutrophils	neutrophil	NNS
cord-028034-pjotppso	16	9	rather	rather	RB
cord-028034-pjotppso	16	10	than	than	IN
cord-028034-pjotppso	16	11	lymphocytes	lymphocyte	NNS
cord-028034-pjotppso	16	12	might	may	MD
cord-028034-pjotppso	16	13	result	result	VB
cord-028034-pjotppso	16	14	in	in	IN
cord-028034-pjotppso	16	15	cytokine	cytokine	NN
cord-028034-pjotppso	16	16	storm	storm	NN
cord-028034-pjotppso	16	17	.	.	.
cord-028034-pjotppso	17	1	[	[	-LRB-
cord-028034-pjotppso	17	2	1	1	CD
cord-028034-pjotppso	17	3	]	]	-RRB-
cord-028034-pjotppso	17	4	[	[	-LRB-
cord-028034-pjotppso	17	5	2	2	CD
cord-028034-pjotppso	17	6	]	]	-RRB-
cord-028034-pjotppso	17	7	[	[	-LRB-
cord-028034-pjotppso	17	8	3	3	CD
cord-028034-pjotppso	17	9	]	]	-RRB-
cord-028034-pjotppso	17	10	[	[	-LRB-
cord-028034-pjotppso	17	11	4	4	CD
cord-028034-pjotppso	17	12	]	]	-RRB-
cord-028034-pjotppso	18	1	Normally	normally	RB
cord-028034-pjotppso	18	2	,	,	,
cord-028034-pjotppso	18	3	neutrophil	neutrophil	NN
cord-028034-pjotppso	18	4	underwent	undergo	VBD
cord-028034-pjotppso	18	5	apoptosis	apoptosis	NN
cord-028034-pjotppso	18	6	after	after	IN
cord-028034-pjotppso	18	7	its	-PRON-	PRP$
cord-028034-pjotppso	18	8	activation	activation	NN
cord-028034-pjotppso	18	9	.	.	.
cord-028034-pjotppso	19	1	5	5	LS
cord-028034-pjotppso	20	1	The	the	DT
cord-028034-pjotppso	20	2	failure	failure	NN
cord-028034-pjotppso	20	3	of	of	IN
cord-028034-pjotppso	20	4	neutrophil	neutrophil	NN
cord-028034-pjotppso	20	5	apoptosis	apoptosis	NN
cord-028034-pjotppso	20	6	might	may	MD
cord-028034-pjotppso	20	7	lead	lead	VB
cord-028034-pjotppso	20	8	to	to	IN
cord-028034-pjotppso	20	9	the	the	DT
cord-028034-pjotppso	20	10	accumulation	accumulation	NN
cord-028034-pjotppso	20	11	of	of	IN
cord-028034-pjotppso	20	12	neutrophil	neutrophil	NN
cord-028034-pjotppso	20	13	and	and	CC
cord-028034-pjotppso	20	14	increase	increase	VB
cord-028034-pjotppso	20	15	the	the	DT
cord-028034-pjotppso	20	16	chance	chance	NN
cord-028034-pjotppso	20	17	of	of	IN
cord-028034-pjotppso	20	18	necrosis	necrosis	NN
cord-028034-pjotppso	20	19	,	,	,
cord-028034-pjotppso	20	20	which	which	WDT
cord-028034-pjotppso	20	21	could	could	MD
cord-028034-pjotppso	20	22	release	release	VB
cord-028034-pjotppso	20	23	the	the	DT
cord-028034-pjotppso	20	24	toxic	toxic	JJ
cord-028034-pjotppso	20	25	intracellular	intracellular	JJ
cord-028034-pjotppso	20	26	components	component	NNS
cord-028034-pjotppso	20	27	and	and	CC
cord-028034-pjotppso	20	28	overactivate	overactivate	VBP
cord-028034-pjotppso	20	29	the	the	DT
cord-028034-pjotppso	20	30	immune	immune	JJ
cord-028034-pjotppso	20	31	system	system	NN
cord-028034-pjotppso	20	32	.	.	.
cord-028034-pjotppso	21	1	5	5	LS
cord-028034-pjotppso	22	1	Interestingly	interestingly	RB
cord-028034-pjotppso	22	2	,	,	,
cord-028034-pjotppso	22	3	administration	administration	NN
cord-028034-pjotppso	22	4	of	of	IN
cord-028034-pjotppso	22	5	vitamin	vitamin	NN
cord-028034-pjotppso	22	6	C	C	NNP
cord-028034-pjotppso	22	7	(	(	-LRB-
cord-028034-pjotppso	22	8	Vc	Vc	NNP
cord-028034-pjotppso	22	9	)	)	-RRB-
cord-028034-pjotppso	22	10	could	could	MD
cord-028034-pjotppso	22	11	decrease	decrease	VB
cord-028034-pjotppso	22	12	the	the	DT
cord-028034-pjotppso	22	13	number	number	NN
cord-028034-pjotppso	22	14	of	of	IN
cord-028034-pjotppso	22	15	neutrophil	neutrophil	NN
cord-028034-pjotppso	22	16	in	in	IN
cord-028034-pjotppso	22	17	septic	septic	JJ
cord-028034-pjotppso	22	18	animals	animal	NNS
cord-028034-pjotppso	22	19	,	,	,
cord-028034-pjotppso	22	20	and	and	CC
cord-028034-pjotppso	22	21	Vc	vc	NN
cord-028034-pjotppso	22	22	-	-	HYPH
cord-028034-pjotppso	22	23	deficient	deficient	JJ
cord-028034-pjotppso	22	24	neutrophils	neutrophil	NNS
cord-028034-pjotppso	22	25	were	be	VBD
cord-028034-pjotppso	22	26	not	not	RB
cord-028034-pjotppso	22	27	efficiently	efficiently	RB
cord-028034-pjotppso	22	28	removed	remove	VBN
cord-028034-pjotppso	22	29	by	by	IN
cord-028034-pjotppso	22	30	macrophages	macrophage	NNS
cord-028034-pjotppso	22	31	.	.	.
cord-028034-pjotppso	23	1	5	5	LS
cord-028034-pjotppso	24	1	In	in	IN
cord-028034-pjotppso	24	2	addition	addition	NN
cord-028034-pjotppso	24	3	,	,	,
cord-028034-pjotppso	24	4	because	because	IN
cord-028034-pjotppso	24	5	the	the	DT
cord-028034-pjotppso	24	6	caspase	caspase	NN
cord-028034-pjotppso	24	7	-	-	HYPH
cord-028034-pjotppso	24	8	dependent	dependent	JJ
cord-028034-pjotppso	24	9	apoptosis	apoptosis	NN
cord-028034-pjotppso	24	10	was	be	VBD
cord-028034-pjotppso	24	11	oxidant	oxidant	JJ
cord-028034-pjotppso	24	12	sensitive	sensitive	JJ
cord-028034-pjotppso	24	13	,	,	,
cord-028034-pjotppso	24	14	Vc	Vc	NNP
cord-028034-pjotppso	24	15	was	be	VBD
cord-028034-pjotppso	24	16	expected	expect	VBN
cord-028034-pjotppso	24	17	to	to	TO
cord-028034-pjotppso	24	18	escort	escort	VB
cord-028034-pjotppso	24	19	the	the	DT
cord-028034-pjotppso	24	20	apoptotic	apoptotic	JJ
cord-028034-pjotppso	24	21	process	process	NN
cord-028034-pjotppso	24	22	and	and	CC
cord-028034-pjotppso	24	23	avoid	avoid	VB
cord-028034-pjotppso	24	24	inflammatory	inflammatory	JJ
cord-028034-pjotppso	24	25	necrosis	necrosis	NN
cord-028034-pjotppso	24	26	following	follow	VBG
cord-028034-pjotppso	24	27	the	the	DT
cord-028034-pjotppso	24	28	activation	activation	NN
cord-028034-pjotppso	24	29	of	of	IN
cord-028034-pjotppso	24	30	neutrophil	neutrophil	NN
cord-028034-pjotppso	24	31	.	.	.
cord-028034-pjotppso	25	1	5	5	LS
cord-028034-pjotppso	26	1	Moreover	moreover	RB
cord-028034-pjotppso	26	2	,	,	,
cord-028034-pjotppso	26	3	neutrophils	neutrophil	NNS
cord-028034-pjotppso	26	4	need	need	VBP
cord-028034-pjotppso	26	5	millimolar	millimolar	JJ
cord-028034-pjotppso	26	6	concentrations	concentration	NNS
cord-028034-pjotppso	26	7	of	of	IN
cord-028034-pjotppso	26	8	intracellular	intracellular	JJ
cord-028034-pjotppso	26	9	Vc	Vc	NNP
cord-028034-pjotppso	26	10	for	for	IN
cord-028034-pjotppso	26	11	their	-PRON-	PRP$
cord-028034-pjotppso	26	12	pathogen	pathogen	NN
cord-028034-pjotppso	26	13	-	-	HYPH
cord-028034-pjotppso	26	14	eradicating	eradicate	VBG
cord-028034-pjotppso	26	15	functions	function	NNS
cord-028034-pjotppso	26	16	and	and	CC
cord-028034-pjotppso	26	17	motility	motility	NN
cord-028034-pjotppso	26	18	.	.	.
cord-028034-pjotppso	27	1	5	5	LS
cord-028034-pjotppso	28	1	Consequently	consequently	RB
cord-028034-pjotppso	28	2	,	,	,
cord-028034-pjotppso	28	3	the	the	DT
cord-028034-pjotppso	28	4	oral	oral	JJ
cord-028034-pjotppso	28	5	administration	administration	NN
cord-028034-pjotppso	28	6	of	of	IN
cord-028034-pjotppso	28	7	sufficient	sufficient	JJ
cord-028034-pjotppso	28	8	Vc	Vc	NNP
cord-028034-pjotppso	28	9	might	may	MD
cord-028034-pjotppso	28	10	be	be	VB
cord-028034-pjotppso	28	11	sufficient	sufficient	JJ
cord-028034-pjotppso	28	12	to	to	TO
cord-028034-pjotppso	28	13	ameliorate	ameliorate	VB
cord-028034-pjotppso	28	14	the	the	DT
cord-028034-pjotppso	28	15	cytokine	cytokine	NN
cord-028034-pjotppso	28	16	storm	storm	NN
cord-028034-pjotppso	28	17	caused	cause	VBN
cord-028034-pjotppso	28	18	by	by	IN
cord-028034-pjotppso	28	19	neutrophils	neutrophil	NNS
cord-028034-pjotppso	28	20	.	.	.
cord-028034-pjotppso	29	1	Interestingly	interestingly	RB
cord-028034-pjotppso	29	2	,	,	,
cord-028034-pjotppso	29	3	a	a	DT
cord-028034-pjotppso	29	4	clinical	clinical	JJ
cord-028034-pjotppso	29	5	trial	trial	NN
cord-028034-pjotppso	29	6	of	of	IN
cord-028034-pjotppso	29	7	high	high	JJ
cord-028034-pjotppso	29	8	-	-	HYPH
cord-028034-pjotppso	29	9	dose	dose	NN
cord-028034-pjotppso	29	10	Vc	Vc	NNP
cord-028034-pjotppso	29	11	infusion	infusion	NN
cord-028034-pjotppso	29	12	for	for	IN
cord-028034-pjotppso	29	13	COVID-19	COVID-19	NNP
cord-028034-pjotppso	29	14	This	this	DT
cord-028034-pjotppso	29	15	is	be	VBZ
cord-028034-pjotppso	29	16	an	an	DT
cord-028034-pjotppso	29	17	open	open	JJ
cord-028034-pjotppso	29	18	access	access	NN
cord-028034-pjotppso	29	19	article	article	NN
cord-028034-pjotppso	29	20	under	under	IN
cord-028034-pjotppso	29	21	the	the	DT
cord-028034-pjotppso	29	22	terms	term	NNS
cord-028034-pjotppso	29	23	of	of	IN
cord-028034-pjotppso	29	24	the	the	DT
cord-028034-pjotppso	29	25	Creative	Creative	NNP
cord-028034-pjotppso	29	26	Commons	Commons	NNP
cord-028034-pjotppso	29	27	Attribution	Attribution	NNP
cord-028034-pjotppso	29	28	License	License	NNP
cord-028034-pjotppso	29	29	,	,	,
cord-028034-pjotppso	29	30	which	which	WDT
cord-028034-pjotppso	29	31	permits	permit	VBZ
cord-028034-pjotppso	29	32	use	use	NN
cord-028034-pjotppso	29	33	,	,	,
cord-028034-pjotppso	29	34	distribution	distribution	NN
cord-028034-pjotppso	29	35	and	and	CC
cord-028034-pjotppso	29	36	reproduction	reproduction	NN
cord-028034-pjotppso	29	37	in	in	IN
cord-028034-pjotppso	29	38	any	any	DT
cord-028034-pjotppso	29	39	medium	medium	NN
cord-028034-pjotppso	29	40	,	,	,
cord-028034-pjotppso	29	41	provided	provide	VBD
cord-028034-pjotppso	29	42	the	the	DT
cord-028034-pjotppso	29	43	original	original	JJ
cord-028034-pjotppso	29	44	work	work	NN
cord-028034-pjotppso	29	45	is	be	VBZ
cord-028034-pjotppso	29	46	properly	properly	RB
cord-028034-pjotppso	29	47	cited	cite	VBN
cord-028034-pjotppso	29	48	.	.	.
cord-028034-pjotppso	30	1	was	be	VBD
cord-028034-pjotppso	30	2	registered	register	VBN
cord-028034-pjotppso	31	1	(	(	-LRB-
cord-028034-pjotppso	31	2	ClinicalTrials	ClinicalTrials	NNP
cord-028034-pjotppso	31	3	:	:	:
cord-028034-pjotppso	31	4	NCT04264533	NCT04264533	NNPS
cord-028034-pjotppso	31	5	)	)	-RRB-
cord-028034-pjotppso	31	6	on	on	IN
cord-028034-pjotppso	31	7	11	11	CD
cord-028034-pjotppso	31	8	February	February	NNP
cord-028034-pjotppso	31	9	2020	2020	CD
cord-028034-pjotppso	31	10	.	.	.
cord-028034-pjotppso	32	1	Th17	Th17	NNP
cord-028034-pjotppso	32	2	,	,	,
cord-028034-pjotppso	32	3	an	an	DT
cord-028034-pjotppso	32	4	interleukin-17	interleukin-17	NN
cord-028034-pjotppso	32	5	(	(	-LRB-
cord-028034-pjotppso	32	6	IL-17	IL-17	NNP
cord-028034-pjotppso	32	7	)	)	-RRB-
cord-028034-pjotppso	32	8	secreting	secrete	VBG
cord-028034-pjotppso	32	9	CD4	CD4	NNP
cord-028034-pjotppso	32	10	+	+	CC
cord-028034-pjotppso	32	11	T	t	NN
cord-028034-pjotppso	32	12	cell	cell	NN
cord-028034-pjotppso	32	13	,	,	,
cord-028034-pjotppso	32	14	has	have	VBZ
cord-028034-pjotppso	32	15	a	a	DT
cord-028034-pjotppso	32	16	unique	unique	JJ
cord-028034-pjotppso	32	17	link	link	NN
cord-028034-pjotppso	32	18	to	to	TO
cord-028034-pjotppso	32	19	augment	augment	VB
cord-028034-pjotppso	32	20	and	and	CC
cord-028034-pjotppso	32	21	coordinate	coordinate	VB
cord-028034-pjotppso	32	22	the	the	DT
cord-028034-pjotppso	32	23	functions	function	NNS
cord-028034-pjotppso	32	24	of	of	IN
cord-028034-pjotppso	32	25	neutrophils	neutrophil	NNS
cord-028034-pjotppso	32	26	.	.	.
cord-028034-pjotppso	33	1	6	6	CD
cord-028034-pjotppso	33	2	Th17	th17	NN
cord-028034-pjotppso	33	3	was	be	VBD
cord-028034-pjotppso	33	4	significantly	significantly	RB
cord-028034-pjotppso	33	5	increased	increase	VBN
cord-028034-pjotppso	33	6	in	in	IN
cord-028034-pjotppso	33	7	the	the	DT
cord-028034-pjotppso	33	8	ICU	ICU	NNP
cord-028034-pjotppso	33	9	patients	patient	NNS
cord-028034-pjotppso	33	10	with	with	IN
cord-028034-pjotppso	33	11	COVID-19	COVID-19	NNP
cord-028034-pjotppso	33	12	.	.	.
cord-028034-pjotppso	34	1	1	1	LS
cord-028034-pjotppso	34	2	IL-6	IL-6	NNP
cord-028034-pjotppso	34	3	is	be	VBZ
cord-028034-pjotppso	34	4	one	one	CD
cord-028034-pjotppso	34	5	of	of	IN
cord-028034-pjotppso	34	6	critical	critical	JJ
cord-028034-pjotppso	34	7	factors	factor	NNS
cord-028034-pjotppso	34	8	for	for	IN
cord-028034-pjotppso	34	9	the	the	DT
cord-028034-pjotppso	34	10	differentiation	differentiation	NN
cord-028034-pjotppso	34	11	and	and	CC
cord-028034-pjotppso	34	12	development	development	NN
cord-028034-pjotppso	34	13	of	of	IN
cord-028034-pjotppso	34	14	Th17	Th17	NNP
cord-028034-pjotppso	34	15	cell	cell	NN
cord-028034-pjotppso	34	16	.	.	.
cord-028034-pjotppso	35	1	6	6	CD
cord-028034-pjotppso	36	1	Tocilizumab	Tocilizumab	NNP
cord-028034-pjotppso	36	2	could	could	MD
cord-028034-pjotppso	36	3	bind	bind	VB
cord-028034-pjotppso	36	4	and	and	CC
cord-028034-pjotppso	36	5	block	block	VB
cord-028034-pjotppso	36	6	the	the	DT
cord-028034-pjotppso	36	7	effects	effect	NNS
cord-028034-pjotppso	36	8	of	of	IN
cord-028034-pjotppso	36	9	IL-6	IL-6	NNP
cord-028034-pjotppso	36	10	and	and	CC
cord-028034-pjotppso	36	11	might	may	MD
cord-028034-pjotppso	36	12	have	have	VB
cord-028034-pjotppso	36	13	a	a	DT
cord-028034-pjotppso	36	14	potential	potential	JJ
cord-028034-pjotppso	36	15	effect	effect	NN
cord-028034-pjotppso	36	16	for	for	IN
cord-028034-pjotppso	36	17	COVID-19	COVID-19	NNP
cord-028034-pjotppso	36	18	treatment	treatment	NN
cord-028034-pjotppso	36	19	,	,	,
cord-028034-pjotppso	36	20	so	so	IN
cord-028034-pjotppso	36	21	that	that	IN
cord-028034-pjotppso	36	22	a	a	DT
cord-028034-pjotppso	36	23	clinical	clinical	JJ
cord-028034-pjotppso	36	24	trial	trial	NN
cord-028034-pjotppso	36	25	was	be	VBD
cord-028034-pjotppso	36	26	also	also	RB
cord-028034-pjotppso	36	27	registered	register	VBN
cord-028034-pjotppso	36	28	(	(	-LRB-
cord-028034-pjotppso	36	29	ChiCTR2000029765	ChiCTR2000029765	VBN
cord-028034-pjotppso	36	30	)	)	-RRB-
cord-028034-pjotppso	36	31	on	on	IN
cord-028034-pjotppso	36	32	13	13	CD
cord-028034-pjotppso	36	33	February	February	NNP
cord-028034-pjotppso	36	34	2020	2020	CD
cord-028034-pjotppso	36	35	.	.	.
cord-028034-pjotppso	37	1	Importantly	importantly	RB
cord-028034-pjotppso	37	2	,	,	,
cord-028034-pjotppso	37	3	1	1	CD
cord-028034-pjotppso	37	4	-	-	SYM
cord-028034-pjotppso	37	5	10	10	CD
cord-028034-pjotppso	37	6	nM	nm	CD
cord-028034-pjotppso	37	7	of	of	IN
cord-028034-pjotppso	37	8	vitamin	vitamin	NN
cord-028034-pjotppso	37	9	D	d	NN
cord-028034-pjotppso	37	10	(	(	-LRB-
cord-028034-pjotppso	37	11	Vd	Vd	NNP
cord-028034-pjotppso	37	12	)	)	-RRB-
cord-028034-pjotppso	37	13	via	via	IN
cord-028034-pjotppso	37	14	vitamin	vitamin	NN
cord-028034-pjotppso	37	15	D	d	NN
cord-028034-pjotppso	37	16	receptor	receptor	NN
cord-028034-pjotppso	37	17	(	(	-LRB-
cord-028034-pjotppso	37	18	VDR	VDR	NNP
cord-028034-pjotppso	37	19	)	)	-RRB-
cord-028034-pjotppso	37	20	could	could	MD
cord-028034-pjotppso	37	21	efficiently	efficiently	RB
cord-028034-pjotppso	37	22	suppress	suppress	VB
cord-028034-pjotppso	37	23	the	the	DT
cord-028034-pjotppso	37	24	cytokine	cytokine	NN
cord-028034-pjotppso	37	25	production	production	NN
cord-028034-pjotppso	37	26	of	of	IN
cord-028034-pjotppso	37	27	Th17	Th17	NNP
cord-028034-pjotppso	37	28	by	by	IN
cord-028034-pjotppso	37	29	inducing	induce	VBG
cord-028034-pjotppso	37	30	the	the	DT
cord-028034-pjotppso	37	31	expression	expression	NN
cord-028034-pjotppso	37	32	of	of	IN
cord-028034-pjotppso	37	33	C	C	NNP
cord-028034-pjotppso	37	34	/	/	SYM
cord-028034-pjotppso	37	35	EBP	ebp	NN
cord-028034-pjotppso	37	36	homologous	homologous	JJ
cord-028034-pjotppso	37	37	protein	protein	NN
cord-028034-pjotppso	37	38	(	(	-LRB-
cord-028034-pjotppso	37	39	CHOP	CHOP	NNP
cord-028034-pjotppso	37	40	)	)	-RRB-
cord-028034-pjotppso	37	41	.	.	.
cord-028034-pjotppso	38	1	7	7	CD
cord-028034-pjotppso	39	1	Together	together	RB
cord-028034-pjotppso	39	2	,	,	,
cord-028034-pjotppso	39	3	the	the	DT
cord-028034-pjotppso	39	4	simultaneous	simultaneous	JJ
cord-028034-pjotppso	39	5	administration	administration	NN
cord-028034-pjotppso	39	6	of	of	IN
cord-028034-pjotppso	39	7	sufficient	sufficient	JJ
cord-028034-pjotppso	39	8	Vc	Vc	NNP
cord-028034-pjotppso	39	9	and	and	CC
cord-028034-pjotppso	39	10	Vd	Vd	NNP
cord-028034-pjotppso	39	11	might	may	MD
cord-028034-pjotppso	39	12	ameliorate	ameliorate	VB
cord-028034-pjotppso	39	13	the	the	DT
cord-028034-pjotppso	39	14	neutrophil	neutrophil	NN
cord-028034-pjotppso	39	15	-	-	HYPH
cord-028034-pjotppso	39	16	related	relate	VBN
cord-028034-pjotppso	39	17	cytokine	cytokine	NN
cord-028034-pjotppso	39	18	storm	storm	NN
cord-028034-pjotppso	39	19	in	in	IN
cord-028034-pjotppso	39	20	the	the	DT
cord-028034-pjotppso	39	21	patients	patient	NNS
cord-028034-pjotppso	39	22	with	with	IN
cord-028034-pjotppso	39	23	COVID-19	COVID-19	NNP
cord-028034-pjotppso	39	24	,	,	,
cord-028034-pjotppso	39	25	especially	especially	RB
cord-028034-pjotppso	39	26	those	those	DT
cord-028034-pjotppso	39	27	under	under	IN
cord-028034-pjotppso	39	28	ICU	ICU	NNP
cord-028034-pjotppso	39	29	(	(	-LRB-
cord-028034-pjotppso	39	30	Figure	figure	NN
cord-028034-pjotppso	39	31	1	1	CD
cord-028034-pjotppso	39	32	)	)	-RRB-
cord-028034-pjotppso	39	33	.	.	.
cord-028034-pjotppso	40	1	Recommended	recommend	VBN
cord-028034-pjotppso	40	2	dietary	dietary	JJ
cord-028034-pjotppso	40	3	allowances	allowance	NNS
cord-028034-pjotppso	40	4	(	(	-LRB-
cord-028034-pjotppso	40	5	RDAs	rda	NNS
cord-028034-pjotppso	40	6	)	)	-RRB-
cord-028034-pjotppso	40	7	for	for	IN
cord-028034-pjotppso	40	8	Vd	Vd	NNP
cord-028034-pjotppso	40	9	are	be	VBP
cord-028034-pjotppso	40	10	as	as	IN
cord-028034-pjotppso	40	11	follows	follow	VBZ
cord-028034-pjotppso	40	12	:	:	:
cord-028034-pjotppso	41	1	800	800	CD
cord-028034-pjotppso	41	2	IU	IU	NNP
cord-028034-pjotppso	41	3	for	for	IN
cord-028034-pjotppso	41	4	a	a	DT
cord-028034-pjotppso	41	5	level	level	NN
cord-028034-pjotppso	41	6	of	of	IN
cord-028034-pjotppso	41	7	20	20	CD
cord-028034-pjotppso	41	8	ng	ng	NN
cord-028034-pjotppso	41	9	/	/	SYM
cord-028034-pjotppso	41	10	mL	ml	NN
cord-028034-pjotppso	41	11	(	(	-LRB-
cord-028034-pjotppso	41	12	50	50	CD
cord-028034-pjotppso	41	13	nM	nm	NN
cord-028034-pjotppso	41	14	)	)	-RRB-
cord-028034-pjotppso	41	15	and	and	CC
cord-028034-pjotppso	41	16	1600	1600	CD
cord-028034-pjotppso	41	17	IU	IU	NNP
cord-028034-pjotppso	41	18	for	for	IN
cord-028034-pjotppso	41	19	a	a	DT
cord-028034-pjotppso	41	20	level	level	NN
cord-028034-pjotppso	41	21	of	of	IN
cord-028034-pjotppso	41	22	30	30	CD
cord-028034-pjotppso	41	23	ng	ng	NN
cord-028034-pjotppso	41	24	/	/	SYM
cord-028034-pjotppso	41	25	mL	ml	NN
cord-028034-pjotppso	41	26	(	(	-LRB-
cord-028034-pjotppso	41	27	75	75	CD
cord-028034-pjotppso	41	28	nM	nm	NN
cord-028034-pjotppso	41	29	)	)	-RRB-
cord-028034-pjotppso	41	30	.	.	.
cord-028034-pjotppso	42	1	8	8	CD
cord-028034-pjotppso	43	1	These	these	DT
cord-028034-pjotppso	43	2	nanomolar	nanomolar	JJ
cord-028034-pjotppso	43	3	concentrations	concentration	NNS
cord-028034-pjotppso	43	4	of	of	IN
cord-028034-pjotppso	43	5	Vd	Vd	NNP
cord-028034-pjotppso	43	6	should	should	MD
cord-028034-pjotppso	43	7	sufficiently	sufficiently	RB
cord-028034-pjotppso	43	8	induce	induce	VB
cord-028034-pjotppso	43	9	CHOP	chop	NN
cord-028034-pjotppso	43	10	expression	expression	NN
cord-028034-pjotppso	43	11	via	via	IN
cord-028034-pjotppso	43	12	VDR	VDR	NNP
cord-028034-pjotppso	43	13	to	to	TO
cord-028034-pjotppso	43	14	inhibit	inhibit	VB
cord-028034-pjotppso	43	15	the	the	DT
cord-028034-pjotppso	43	16	cytokine	cytokine	NN
cord-028034-pjotppso	43	17	production	production	NN
cord-028034-pjotppso	43	18	of	of	IN
cord-028034-pjotppso	43	19	Th17	Th17	NNP
cord-028034-pjotppso	44	1	and	and	CC
cord-028034-pjotppso	44	2	the	the	DT
cord-028034-pjotppso	44	3	Th17-related	Th17-related	NNP
cord-028034-pjotppso	44	4	augmentation	augmentation	NN
cord-028034-pjotppso	44	5	of	of	IN
cord-028034-pjotppso	44	6	neutrophils	neutrophil	NNS
cord-028034-pjotppso	44	7	.	.	.
cord-028034-pjotppso	45	1	7	7	CD
cord-028034-pjotppso	46	1	Based	base	VBN
cord-028034-pjotppso	46	2	on	on	IN
cord-028034-pjotppso	46	3	the	the	DT
cord-028034-pjotppso	46	4	many	many	JJ
cord-028034-pjotppso	46	5	mechanisms	mechanism	NNS
cord-028034-pjotppso	46	6	of	of	IN
cord-028034-pjotppso	46	7	Vd	Vd	NNP
cord-028034-pjotppso	46	8	reducing	reduce	VBG
cord-028034-pjotppso	46	9	the	the	DT
cord-028034-pjotppso	46	10	risk	risk	NN
cord-028034-pjotppso	46	11	of	of	IN
cord-028034-pjotppso	46	12	viral	viral	JJ
cord-028034-pjotppso	46	13	infections	infection	NNS
cord-028034-pjotppso	46	14	,	,	,
cord-028034-pjotppso	46	15	Grant	Grant	NNP
cord-028034-pjotppso	46	16	et	et	NNP
cord-028034-pjotppso	46	17	al	al	NNP
cord-028034-pjotppso	46	18	recommended	recommend	VBD
cord-028034-pjotppso	46	19	that	that	IN
cord-028034-pjotppso	46	20	a	a	DT
cord-028034-pjotppso	46	21	daily	daily	JJ
cord-028034-pjotppso	46	22	dose	dose	NN
cord-028034-pjotppso	46	23	(	(	-LRB-
cord-028034-pjotppso	46	24	10	10	CD
cord-028034-pjotppso	46	25	000	000	CD
cord-028034-pjotppso	46	26	IU	IU	NNP
cord-028034-pjotppso	46	27	)	)	-RRB-
cord-028034-pjotppso	46	28	of	of	IN
cord-028034-pjotppso	46	29	Vd	Vd	NNP
cord-028034-pjotppso	46	30	should	should	MD
cord-028034-pjotppso	46	31	be	be	VB
cord-028034-pjotppso	46	32	taken	take	VBN
cord-028034-pjotppso	46	33	to	to	TO
cord-028034-pjotppso	46	34	achieve	achieve	VB
cord-028034-pjotppso	46	35	an	an	DT
cord-028034-pjotppso	46	36	optimal	optimal	JJ
cord-028034-pjotppso	46	37	level	level	NN
cord-028034-pjotppso	46	38	of	of	IN
cord-028034-pjotppso	46	39	40	40	CD
cord-028034-pjotppso	46	40	-	-	SYM
cord-028034-pjotppso	46	41	60	60	CD
cord-028034-pjotppso	46	42	ng	ng	NN
cord-028034-pjotppso	46	43	/	/	SYM
cord-028034-pjotppso	46	44	mL	ml	NN
cord-028034-pjotppso	46	45	(	(	-LRB-
cord-028034-pjotppso	46	46	100	100	CD
cord-028034-pjotppso	46	47	-	-	SYM
cord-028034-pjotppso	46	48	150	150	CD
cord-028034-pjotppso	46	49	nM	nM	NNP
cord-028034-pjotppso	46	50	)	)	-RRB-
cord-028034-pjotppso	46	51	,	,	,
cord-028034-pjotppso	46	52	and	and	CC
cord-028034-pjotppso	46	53	claimed	claim	VBD
cord-028034-pjotppso	46	54	without	without	IN
cord-028034-pjotppso	46	55	adverse	adverse	JJ
cord-028034-pjotppso	46	56	effects	effect	NNS
cord-028034-pjotppso	46	57	.	.	.
cord-028034-pjotppso	47	1	9	9	CD
cord-028034-pjotppso	48	1	However	however	RB
cord-028034-pjotppso	48	2	,	,	,
cord-028034-pjotppso	48	3	a	a	DT
cord-028034-pjotppso	48	4	recent	recent	JJ
cord-028034-pjotppso	48	5	preprint	preprint	NN
cord-028034-pjotppso	48	6	of	of	IN
cord-028034-pjotppso	48	7	medRxiv	medRxiv	NNS
cord-028034-pjotppso	48	8	about	about	IN
cord-028034-pjotppso	48	9	Vd	Vd	NNP
cord-028034-pjotppso	48	10	suppressing	suppress	VBG
cord-028034-pjotppso	48	11	cytokine	cytokine	JJ
cord-028034-pjotppso	48	12	storm	storm	NN
cord-028034-pjotppso	48	13	in	in	IN
cord-028034-pjotppso	49	1	COVID-19	covid-19	JJ
cord-028034-pjotppso	49	2	patients	patient	NNS
cord-028034-pjotppso	49	3	was	be	VBD
cord-028034-pjotppso	49	4	withdrawn	withdraw	VBN
cord-028034-pjotppso	49	5	by	by	IN
cord-028034-pjotppso	49	6	the	the	DT
cord-028034-pjotppso	49	7	authors	author	NNS
cord-028034-pjotppso	49	8	because	because	IN
cord-028034-pjotppso	49	9	they	-PRON-	PRP
cord-028034-pjotppso	49	10	noticed	notice	VBD
cord-028034-pjotppso	49	11	the	the	DT
cord-028034-pjotppso	49	12	idiosyncrasy	idiosyncrasy	NN
cord-028034-pjotppso	49	13	of	of	IN
cord-028034-pjotppso	49	14	Vd	Vd	NNP
cord-028034-pjotppso	49	15	across	across	IN
cord-028034-pjotppso	49	16	different	different	JJ
cord-028034-pjotppso	49	17	countries	country	NNS
cord-028034-pjotppso	49	18	.	.	.
cord-028034-pjotppso	50	1	10	10	CD
cord-028034-pjotppso	51	1	In	in	IN
cord-028034-pjotppso	51	2	general	general	JJ
cord-028034-pjotppso	51	3	,	,	,
cord-028034-pjotppso	51	4	as	as	IN
cord-028034-pjotppso	51	5	for	for	IN
cord-028034-pjotppso	51	6	the	the	DT
cord-028034-pjotppso	51	7	prevention	prevention	NN
cord-028034-pjotppso	51	8	or	or	CC
cord-028034-pjotppso	51	9	treatments	treatment	NNS
cord-028034-pjotppso	51	10	of	of	IN
cord-028034-pjotppso	51	11	the	the	DT
cord-028034-pjotppso	51	12	neutrophil	neutrophil	NN
cord-028034-pjotppso	51	13	-	-	HYPH
cord-028034-pjotppso	51	14	related	relate	VBN
cord-028034-pjotppso	51	15	cytokine	cytokine	NN
cord-028034-pjotppso	51	16	storm	storm	NN
cord-028034-pjotppso	51	17	,	,	,
cord-028034-pjotppso	51	18	to	to	TO
cord-028034-pjotppso	51	19	meet	meet	VB
cord-028034-pjotppso	51	20	the	the	DT
cord-028034-pjotppso	51	21	requirements	requirement	NNS
cord-028034-pjotppso	51	22	of	of	IN
cord-028034-pjotppso	51	23	50	50	CD
cord-028034-pjotppso	51	24	%	%	NN
cord-028034-pjotppso	51	25	of	of	IN
cord-028034-pjotppso	51	26	the	the	DT
cord-028034-pjotppso	51	27	population	population	NN
cord-028034-pjotppso	51	28	,	,	,
cord-028034-pjotppso	51	29	a	a	DT
cord-028034-pjotppso	51	30	400	400	CD
cord-028034-pjotppso	51	31	-	-	SYM
cord-028034-pjotppso	51	32	600	600	CD
cord-028034-pjotppso	51	33	IU	IU	NNP
cord-028034-pjotppso	51	34	daily	daily	JJ
cord-028034-pjotppso	51	35	dose	dose	NN
cord-028034-pjotppso	51	36	of	of	IN
cord-028034-pjotppso	51	37	Vd	Vd	NNP
cord-028034-pjotppso	51	38	should	should	MD
cord-028034-pjotppso	51	39	be	be	VB
cord-028034-pjotppso	51	40	safe	safe	JJ
cord-028034-pjotppso	51	41	and	and	CC
cord-028034-pjotppso	51	42	sufficient	sufficient	JJ
cord-028034-pjotppso	51	43	,	,	,
cord-028034-pjotppso	51	44	whereas	whereas	IN
cord-028034-pjotppso	51	45	the	the	DT
cord-028034-pjotppso	51	46	RDA	RDA	NNP
cord-028034-pjotppso	51	47	of	of	IN
cord-028034-pjotppso	51	48	Vd	Vd	NNP
cord-028034-pjotppso	51	49	(	(	-LRB-
cord-028034-pjotppso	51	50	800	800	CD
cord-028034-pjotppso	51	51	-	-	CD
cord-028034-pjotppso	51	52	1600	1600	CD
cord-028034-pjotppso	51	53	IU	IU	NNP
cord-028034-pjotppso	51	54	daily	daily	RB
cord-028034-pjotppso	51	55	)	)	-RRB-
cord-028034-pjotppso	51	56	could	could	MD
cord-028034-pjotppso	51	57	meet	meet	VB
cord-028034-pjotppso	51	58	the	the	DT
cord-028034-pjotppso	51	59	needs	need	NNS
cord-028034-pjotppso	51	60	of	of	IN
cord-028034-pjotppso	51	61	97.5	97.5	CD
cord-028034-pjotppso	51	62	%	%	NN
cord-028034-pjotppso	51	63	of	of	IN
cord-028034-pjotppso	51	64	individuals	individual	NNS
cord-028034-pjotppso	51	65	.	.	.
cord-028034-pjotppso	52	1	8	8	CD
cord-028034-pjotppso	53	1	Considering	consider	VBG
cord-028034-pjotppso	53	2	that	that	IN
cord-028034-pjotppso	53	3	Vc	Vc	NNP
cord-028034-pjotppso	53	4	could	could	MD
cord-028034-pjotppso	53	5	hinder	hinder	VB
cord-028034-pjotppso	53	6	the	the	DT
cord-028034-pjotppso	53	7	function	function	NN
cord-028034-pjotppso	53	8	of	of	IN
cord-028034-pjotppso	53	9	interferon	interferon	NN
cord-028034-pjotppso	53	10	-	-	HYPH
cord-028034-pjotppso	53	11	gamma	gamma	NN
cord-028034-pjotppso	53	12	11	11	CD
cord-028034-pjotppso	53	13	and	and	CC
cord-028034-pjotppso	53	14	that	that	DT
cord-028034-pjotppso	53	15	leukocytes	leukocyte	NNS
cord-028034-pjotppso	53	16	including	include	VBG
cord-028034-pjotppso	53	17	neutrophils	neutrophil	NNS
cord-028034-pjotppso	53	18	and	and	CC
cord-028034-pjotppso	53	19	monocytes	monocyte	NNS
cord-028034-pjotppso	53	20	accumulate	accumulate	VBP
cord-028034-pjotppso	53	21	maximal	maximal	JJ
cord-028034-pjotppso	53	22	Vc	Vc	NNP
cord-028034-pjotppso	53	23	concentrations	concentration	NNS
cord-028034-pjotppso	53	24	at	at	IN
cord-028034-pjotppso	53	25	MedComm	MedComm	NNP
cord-028034-pjotppso	53	26	.	.	.
cord-028034-pjotppso	54	1	2020;1:81	2020;1:81	CD
cord-028034-pjotppso	54	2	-	-	SYM
cord-028034-pjotppso	54	3	83	83	CD
cord-028034-pjotppso	54	4	.	.	.
cord-028034-pjotppso	55	1	wileyonlinelibrary.com/journal/mco2	wileyonlinelibrary.com/journal/mco2	JJ
cord-028034-pjotppso	56	1	81	81	CD
cord-028034-pjotppso	57	1	F	F	NNP
cord-028034-pjotppso	57	2	I	i	NN
cord-028034-pjotppso	57	3	G	g	NN
cord-028034-pjotppso	58	1	U	u	NN
cord-028034-pjotppso	58	2	R	r	NN
cord-028034-pjotppso	58	3	E	e	NN
cord-028034-pjotppso	58	4	1	1	CD
cord-028034-pjotppso	58	5	Vitamin	vitamin	NN
cord-028034-pjotppso	58	6	Intervention	intervention	NN
cord-028034-pjotppso	58	7	for	for	IN
cord-028034-pjotppso	58	8	neutrophil	neutrophil	NN
cord-028034-pjotppso	58	9	-	-	HYPH
cord-028034-pjotppso	58	10	related	relate	VBN
cord-028034-pjotppso	58	11	cytokine	cytokine	NN
cord-028034-pjotppso	58	12	storm	storm	NN
cord-028034-pjotppso	58	13	.	.	.
cord-028034-pjotppso	59	1	Neutrophil	Neutrophil	NNP
cord-028034-pjotppso	59	2	-	-	HYPH
cord-028034-pjotppso	59	3	related	relate	VBN
cord-028034-pjotppso	59	4	cytokine	cytokine	NN
cord-028034-pjotppso	59	5	storm	storm	NN
cord-028034-pjotppso	59	6	was	be	VBD
cord-028034-pjotppso	59	7	reported	report	VBN
cord-028034-pjotppso	59	8	to	to	TO
cord-028034-pjotppso	59	9	be	be	VB
cord-028034-pjotppso	59	10	associated	associate	VBN
cord-028034-pjotppso	59	11	with	with	IN
cord-028034-pjotppso	59	12	the	the	DT
cord-028034-pjotppso	59	13	severity	severity	NN
cord-028034-pjotppso	59	14	and	and	CC
cord-028034-pjotppso	59	15	death	death	NN
cord-028034-pjotppso	59	16	of	of	IN
cord-028034-pjotppso	59	17	patients	patient	NNS
cord-028034-pjotppso	59	18	with	with	IN
cord-028034-pjotppso	59	19	COVID-19	COVID-19	NNP
cord-028034-pjotppso	59	20	.	.	.
cord-028034-pjotppso	60	1	Th17	Th17	NNP
cord-028034-pjotppso	60	2	,	,	,
cord-028034-pjotppso	60	3	an	an	DT
cord-028034-pjotppso	60	4	IL-17	IL-17	NNP
cord-028034-pjotppso	60	5	secreting	secrete	VBG
cord-028034-pjotppso	60	6	CD4	CD4	NNP
cord-028034-pjotppso	60	7	+	+	CC
cord-028034-pjotppso	60	8	T	t	NN
cord-028034-pjotppso	60	9	cell	cell	NN
cord-028034-pjotppso	60	10	,	,	,
cord-028034-pjotppso	60	11	has	have	VBZ
cord-028034-pjotppso	60	12	a	a	DT
cord-028034-pjotppso	60	13	unique	unique	JJ
cord-028034-pjotppso	60	14	link	link	NN
cord-028034-pjotppso	60	15	to	to	TO
cord-028034-pjotppso	60	16	augment	augment	VB
cord-028034-pjotppso	60	17	the	the	DT
cord-028034-pjotppso	60	18	function	function	NN
cord-028034-pjotppso	60	19	of	of	IN
cord-028034-pjotppso	60	20	neutrophil	neutrophil	NN
cord-028034-pjotppso	60	21	.	.	.
cord-028034-pjotppso	61	1	Vitamin	vitamin	NN
cord-028034-pjotppso	61	2	D	d	NN
cord-028034-pjotppso	61	3	via	via	IN
cord-028034-pjotppso	61	4	vitamin	vitamin	NN
cord-028034-pjotppso	61	5	D	d	NN
cord-028034-pjotppso	61	6	receptor	receptor	NN
cord-028034-pjotppso	61	7	(	(	-LRB-
cord-028034-pjotppso	61	8	VDR	VDR	NNP
cord-028034-pjotppso	61	9	)	)	-RRB-
cord-028034-pjotppso	61	10	could	could	MD
cord-028034-pjotppso	61	11	efficiently	efficiently	RB
cord-028034-pjotppso	61	12	suppress	suppress	VB
cord-028034-pjotppso	61	13	the	the	DT
cord-028034-pjotppso	61	14	cytokine	cytokine	NN
cord-028034-pjotppso	61	15	production	production	NN
cord-028034-pjotppso	61	16	of	of	IN
cord-028034-pjotppso	61	17	Th17	Th17	NNP
cord-028034-pjotppso	61	18	.	.	.
cord-028034-pjotppso	62	1	Vitamin	vitamin	NN
cord-028034-pjotppso	62	2	C	c	NN
cord-028034-pjotppso	62	3	could	could	MD
cord-028034-pjotppso	62	4	decrease	decrease	VB
cord-028034-pjotppso	62	5	the	the	DT
cord-028034-pjotppso	62	6	number	number	NN
cord-028034-pjotppso	62	7	of	of	IN
cord-028034-pjotppso	62	8	neutrophils	neutrophil	NNS
cord-028034-pjotppso	62	9	,	,	,
cord-028034-pjotppso	62	10	escort	escort	VB
cord-028034-pjotppso	62	11	the	the	DT
cord-028034-pjotppso	62	12	apoptotic	apoptotic	JJ
cord-028034-pjotppso	62	13	process	process	NN
cord-028034-pjotppso	62	14	,	,	,
cord-028034-pjotppso	62	15	and	and	CC
cord-028034-pjotppso	62	16	avoid	avoid	VB
cord-028034-pjotppso	62	17	inflammatory	inflammatory	JJ
cord-028034-pjotppso	62	18	necrosis	necrosis	NN
cord-028034-pjotppso	62	19	following	follow	VBG
cord-028034-pjotppso	62	20	the	the	DT
cord-028034-pjotppso	62	21	activation	activation	NN
cord-028034-pjotppso	62	22	of	of	IN
cord-028034-pjotppso	62	23	neutrophil	neutrophil	NN
cord-028034-pjotppso	62	24	dietary	dietary	JJ
cord-028034-pjotppso	62	25	intakes	intake	NNS
cord-028034-pjotppso	62	26	of	of	IN
cord-028034-pjotppso	62	27	∼100	∼100	NNP
cord-028034-pjotppso	62	28	mg	mg	NNP
cord-028034-pjotppso	62	29	/	/	SYM
cord-028034-pjotppso	62	30	day	day	NN
cord-028034-pjotppso	62	31	,	,	,
cord-028034-pjotppso	62	32	5	5	CD
cord-028034-pjotppso	62	33	it	-PRON-	PRP
cord-028034-pjotppso	62	34	is	be	VBZ
cord-028034-pjotppso	62	35	important	important	JJ
cord-028034-pjotppso	62	36	to	to	TO
cord-028034-pjotppso	62	37	use	use	VB
cord-028034-pjotppso	62	38	safe	safe	JJ
cord-028034-pjotppso	62	39	dose	dose	NN
cord-028034-pjotppso	62	40	for	for	IN
cord-028034-pjotppso	62	41	the	the	DT
cord-028034-pjotppso	62	42	intervention	intervention	NN
cord-028034-pjotppso	62	43	of	of	IN
cord-028034-pjotppso	62	44	neutrophil	neutrophil	NN
cord-028034-pjotppso	62	45	-	-	HYPH
cord-028034-pjotppso	62	46	related	relate	VBN
cord-028034-pjotppso	62	47	cytokine	cytokine	NN
cord-028034-pjotppso	62	48	storm	storm	NN
cord-028034-pjotppso	62	49	and	and	CC
cord-028034-pjotppso	62	50	avoid	avoid	VB
cord-028034-pjotppso	62	51	slowing	slow	VBG
cord-028034-pjotppso	62	52	the	the	DT
cord-028034-pjotppso	62	53	clearance	clearance	NN
cord-028034-pjotppso	62	54	of	of	IN
cord-028034-pjotppso	62	55	viruses	virus	NNS
cord-028034-pjotppso	62	56	by	by	IN
cord-028034-pjotppso	62	57	immune	immune	JJ
cord-028034-pjotppso	62	58	response	response	NN
cord-028034-pjotppso	62	59	.	.	.
cord-028034-pjotppso	63	1	RDA	RDA	NNP
cord-028034-pjotppso	63	2	for	for	IN
cord-028034-pjotppso	63	3	Vc	Vc	NNP
cord-028034-pjotppso	63	4	is	be	VBZ
cord-028034-pjotppso	63	5	about	about	RB
cord-028034-pjotppso	63	6	90	90	CD
cord-028034-pjotppso	63	7	mg	mg	NNP
cord-028034-pjotppso	63	8	daily	daily	RB
cord-028034-pjotppso	63	9	,	,	,
cord-028034-pjotppso	63	10	interestingly	interestingly	RB
cord-028034-pjotppso	63	11	,	,	,
cord-028034-pjotppso	63	12	which	which	WDT
cord-028034-pjotppso	63	13	was	be	VBD
cord-028034-pjotppso	63	14	selected	select	VBN
cord-028034-pjotppso	63	15	at	at	IN
cord-028034-pjotppso	63	16	80	80	CD
cord-028034-pjotppso	63	17	%	%	NN
cord-028034-pjotppso	63	18	saturation	saturation	NN
cord-028034-pjotppso	63	19	of	of	IN
cord-028034-pjotppso	63	20	neutrophils	neutrophil	NNS
cord-028034-pjotppso	63	21	.	.	.
cord-028034-pjotppso	64	1	12	12	CD
cord-028034-pjotppso	64	2	Levin	Levin	NNP
cord-028034-pjotppso	64	3	et	et	NNP
cord-028034-pjotppso	64	4	al	al	NNP
cord-028034-pjotppso	64	5	suggested	suggest	VBD
cord-028034-pjotppso	64	6	that	that	IN
cord-028034-pjotppso	64	7	the	the	DT
cord-028034-pjotppso	64	8	safe	safe	JJ
cord-028034-pjotppso	64	9	dose	dose	NN
cord-028034-pjotppso	64	10	of	of	IN
cord-028034-pjotppso	64	11	Vc	Vc	NNP
cord-028034-pjotppso	64	12	was	be	VBD
cord-028034-pjotppso	64	13	less	less	JJR
cord-028034-pjotppso	64	14	than	than	IN
cord-028034-pjotppso	64	15	1000	1000	CD
cord-028034-pjotppso	64	16	mg	mg	NNP
cord-028034-pjotppso	64	17	daily	daily	RB
cord-028034-pjotppso	64	18	.	.	.
cord-028034-pjotppso	65	1	13	13	CD
cord-028034-pjotppso	66	1	Wang	Wang	NNP
cord-028034-pjotppso	66	2	et	et	NNP
cord-028034-pjotppso	66	3	al	al	NNP
cord-028034-pjotppso	66	4	recently	recently	RB
cord-028034-pjotppso	66	5	suggested	suggest	VBD
cord-028034-pjotppso	66	6	that	that	IN
cord-028034-pjotppso	66	7	Vc	Vc	NNP
cord-028034-pjotppso	66	8	and	and	CC
cord-028034-pjotppso	66	9	Vitamin	vitamin	NN
cord-028034-pjotppso	66	10	E	e	NN
cord-028034-pjotppso	66	11	(	(	-LRB-
cord-028034-pjotppso	66	12	Ve	Ve	NNP
cord-028034-pjotppso	66	13	)	)	-RRB-
cord-028034-pjotppso	66	14	might	may	MD
cord-028034-pjotppso	66	15	ameliorate	ameliorate	VB
cord-028034-pjotppso	66	16	cardiac	cardiac	JJ
cord-028034-pjotppso	66	17	injuries	injury	NNS
cord-028034-pjotppso	66	18	of	of	IN
cord-028034-pjotppso	66	19	COVID-19	covid-19	JJ
cord-028034-pjotppso	66	20	patients	patient	NNS
cord-028034-pjotppso	66	21	as	as	IN
cord-028034-pjotppso	66	22	an	an	DT
cord-028034-pjotppso	66	23	antioxidant	antioxidant	NN
cord-028034-pjotppso	66	24	.	.	.
cord-028034-pjotppso	66	25	14	14	CD
cord-028034-pjotppso	67	1	Compared	compare	VBN
cord-028034-pjotppso	67	2	to	to	IN
cord-028034-pjotppso	67	3	other	other	JJ
cord-028034-pjotppso	67	4	antioxidants	antioxidant	NNS
cord-028034-pjotppso	67	5	and	and	CC
cord-028034-pjotppso	67	6	water	water	NN
cord-028034-pjotppso	67	7	-	-	HYPH
cord-028034-pjotppso	67	8	insoluble	insoluble	JJ
cord-028034-pjotppso	67	9	Ve	Ve	NNP
cord-028034-pjotppso	67	10	,	,	,
cord-028034-pjotppso	67	11	Vc	Vc	NNP
cord-028034-pjotppso	67	12	and	and	CC
cord-028034-pjotppso	67	13	Vd	Vd	NNP
cord-028034-pjotppso	67	14	are	be	VBP
cord-028034-pjotppso	67	15	preferred	prefer	VBN
cord-028034-pjotppso	67	16	natural	natural	JJ
cord-028034-pjotppso	67	17	substrates	substrate	NNS
cord-028034-pjotppso	67	18	15	15	CD
cord-028034-pjotppso	67	19	and	and	CC
cord-028034-pjotppso	67	20	modulators	modulator	NNS
cord-028034-pjotppso	67	21	of	of	IN
cord-028034-pjotppso	67	22	neutrophil	neutrophil	NN
cord-028034-pjotppso	67	23	function	function	NN
cord-028034-pjotppso	67	24	and	and	CC
cord-028034-pjotppso	67	25	fate	fate	NN
cord-028034-pjotppso	67	26	.	.	.
cord-028034-pjotppso	68	1	In	in	IN
cord-028034-pjotppso	68	2	brief	brief	NN
cord-028034-pjotppso	68	3	,	,	,
cord-028034-pjotppso	68	4	an	an	DT
cord-028034-pjotppso	68	5	oral	oral	JJ
cord-028034-pjotppso	68	6	daily	daily	JJ
cord-028034-pjotppso	68	7	dose	dose	NN
cord-028034-pjotppso	68	8	of	of	IN
cord-028034-pjotppso	68	9	Vc	Vc	NNP
cord-028034-pjotppso	68	10	between	between	IN
cord-028034-pjotppso	68	11	90	90	CD
cord-028034-pjotppso	68	12	and	and	CC
cord-028034-pjotppso	68	13	1000	1000	CD
cord-028034-pjotppso	68	14	mg	mg	PRP
cord-028034-pjotppso	68	15	might	may	MD
cord-028034-pjotppso	68	16	avoid	avoid	VB
cord-028034-pjotppso	68	17	inhibiting	inhibit	VBG
cord-028034-pjotppso	68	18	innate	innate	JJ
cord-028034-pjotppso	68	19	immunity	immunity	NN
cord-028034-pjotppso	68	20	and	and	CC
cord-028034-pjotppso	68	21	safeguard	safeguard	VB
cord-028034-pjotppso	68	22	the	the	DT
cord-028034-pjotppso	68	23	homeostasis	homeostasis	NN
cord-028034-pjotppso	68	24	of	of	IN
cord-028034-pjotppso	68	25	neutrophils	neutrophil	NNS
cord-028034-pjotppso	68	26	.	.	.
cord-028034-pjotppso	69	1	On	on	IN
cord-028034-pjotppso	69	2	the	the	DT
cord-028034-pjotppso	69	3	other	other	JJ
cord-028034-pjotppso	69	4	hand	hand	NN
cord-028034-pjotppso	69	5	,	,	,
cord-028034-pjotppso	69	6	Cheng	Cheng	NNP
cord-028034-pjotppso	69	7	discussed	discuss	VBD
cord-028034-pjotppso	69	8	that	that	IN
cord-028034-pjotppso	69	9	Vc	Vc	NNP
cord-028034-pjotppso	69	10	up	up	IN
cord-028034-pjotppso	69	11	to	to	TO
cord-028034-pjotppso	69	12	1.5	1.5	CD
cord-028034-pjotppso	69	13	g	g	NN
cord-028034-pjotppso	69	14	/	/	SYM
cord-028034-pjotppso	69	15	kg	kg	NN
cord-028034-pjotppso	69	16	body	body	NN
cord-028034-pjotppso	69	17	weight	weight	NN
cord-028034-pjotppso	69	18	might	may	MD
cord-028034-pjotppso	69	19	be	be	VB
cord-028034-pjotppso	69	20	safe	safe	JJ
cord-028034-pjotppso	69	21	and	and	CC
cord-028034-pjotppso	69	22	without	without	IN
cord-028034-pjotppso	69	23	major	major	JJ
cord-028034-pjotppso	69	24	adverse	adverse	JJ
cord-028034-pjotppso	69	25	events	event	NNS
cord-028034-pjotppso	69	26	16	16	CD
cord-028034-pjotppso	69	27	,	,	,
cord-028034-pjotppso	69	28	and	and	CC
cord-028034-pjotppso	69	29	cited	cite	VBD
cord-028034-pjotppso	69	30	that	that	IN
cord-028034-pjotppso	69	31	high	high	JJ
cord-028034-pjotppso	69	32	-	-	HYPH
cord-028034-pjotppso	69	33	dose	dose	NN
cord-028034-pjotppso	69	34	intravenous	intravenous	JJ
cord-028034-pjotppso	69	35	Vc	Vc	NNP
cord-028034-pjotppso	69	36	(	(	-LRB-
cord-028034-pjotppso	69	37	50	50	CD
cord-028034-pjotppso	69	38	-	-	SYM
cord-028034-pjotppso	69	39	200	200	CD
cord-028034-pjotppso	69	40	mg	mg	NNP
cord-028034-pjotppso	69	41	/	/	SYM
cord-028034-pjotppso	69	42	kg	kg	NN
cord-028034-pjotppso	69	43	body	body	NN
cord-028034-pjotppso	69	44	weight	weight	NN
cord-028034-pjotppso	69	45	)	)	-RRB-
cord-028034-pjotppso	69	46	was	be	VBD
cord-028034-pjotppso	69	47	recommended	recommend	VBN
cord-028034-pjotppso	69	48	in	in	IN
cord-028034-pjotppso	69	49	the	the	DT
cord-028034-pjotppso	69	50	expert	expert	JJ
cord-028034-pjotppso	69	51	consensus	consensus	NN
cord-028034-pjotppso	69	52	statement	statement	NN
cord-028034-pjotppso	69	53	on	on	IN
cord-028034-pjotppso	69	54	comprehensive	comprehensive	JJ
cord-028034-pjotppso	69	55	treatment	treatment	NN
cord-028034-pjotppso	69	56	of	of	IN
cord-028034-pjotppso	69	57	COVID-19	COVID-19	NNP
cord-028034-pjotppso	69	58	from	from	IN
cord-028034-pjotppso	69	59	Shanghai	Shanghai	NNP
cord-028034-pjotppso	69	60	,	,	,
cord-028034-pjotppso	69	61	China	China	NNP
cord-028034-pjotppso	69	62	.	.	.
cord-028034-pjotppso	70	1	17	17	CD
cord-028034-pjotppso	71	1	The	the	DT
cord-028034-pjotppso	71	2	high	high	JJ
cord-028034-pjotppso	71	3	-	-	HYPH
cord-028034-pjotppso	71	4	dose	dose	NN
cord-028034-pjotppso	71	5	intravenous	intravenous	JJ
cord-028034-pjotppso	71	6	Vc	Vc	NNP
cord-028034-pjotppso	71	7	might	may	MD
cord-028034-pjotppso	71	8	act	act	VB
cord-028034-pjotppso	71	9	as	as	IN
cord-028034-pjotppso	71	10	a	a	DT
cord-028034-pjotppso	71	11	pro	pro	JJ
cord-028034-pjotppso	71	12	-	-	JJ
cord-028034-pjotppso	71	13	oxidant	oxidant	JJ
cord-028034-pjotppso	71	14	in	in	IN
cord-028034-pjotppso	71	15	immune	immune	JJ
cord-028034-pjotppso	71	16	cells	cell	NNS
cord-028034-pjotppso	71	17	and	and	CC
cord-028034-pjotppso	71	18	induce	induce	VB
cord-028034-pjotppso	71	19	glyceraldehyde-3-phosphate	glyceraldehyde-3-phosphate	JJ
cord-028034-pjotppso	71	20	dehydrogenase	dehydrogenase	NN
cord-028034-pjotppso	71	21	inhibition	inhibition	NN
cord-028034-pjotppso	71	22	and	and	CC
cord-028034-pjotppso	71	23	related	related	JJ
cord-028034-pjotppso	71	24	immunosuppression	immunosuppression	NN
cord-028034-pjotppso	71	25	via	via	IN
cord-028034-pjotppso	71	26	NAD	NAD	NNP
cord-028034-pjotppso	71	27	+	+	CC
cord-028034-pjotppso	71	28	(	(	-LRB-
cord-028034-pjotppso	71	29	nicotinamide	nicotinamide	NN
cord-028034-pjotppso	71	30	adenine	adenine	NN
cord-028034-pjotppso	71	31	dinucleotide	dinucleotide	NN
cord-028034-pjotppso	71	32	)	)	-RRB-
cord-028034-pjotppso	71	33	depletion	depletion	NN
cord-028034-pjotppso	71	34	.	.	.
cord-028034-pjotppso	72	1	18	18	CD
cord-028034-pjotppso	73	1	Due	due	IN
cord-028034-pjotppso	73	2	to	to	IN
cord-028034-pjotppso	73	3	the	the	DT
cord-028034-pjotppso	73	4	roles	role	NNS
cord-028034-pjotppso	73	5	of	of	IN
cord-028034-pjotppso	73	6	high	high	JJ
cord-028034-pjotppso	73	7	-	-	HYPH
cord-028034-pjotppso	73	8	dose	dose	NN
cord-028034-pjotppso	73	9	Vc	Vc	NNP
cord-028034-pjotppso	73	10	in	in	IN
cord-028034-pjotppso	73	11	immunosuppression	immunosuppression	NN
cord-028034-pjotppso	73	12	,	,	,
cord-028034-pjotppso	73	13	the	the	DT
cord-028034-pjotppso	73	14	dosage	dosage	NN
cord-028034-pjotppso	73	15	of	of	IN
cord-028034-pjotppso	73	16	Vc	Vc	NNP
cord-028034-pjotppso	73	17	should	should	MD
cord-028034-pjotppso	73	18	be	be	VB
cord-028034-pjotppso	73	19	deliberated	deliberate	VBN
cord-028034-pjotppso	73	20	on	on	IN
cord-028034-pjotppso	73	21	the	the	DT
cord-028034-pjotppso	73	22	details	detail	NNS
cord-028034-pjotppso	73	23	to	to	TO
cord-028034-pjotppso	73	24	take	take	VB
cord-028034-pjotppso	73	25	into	into	IN
cord-028034-pjotppso	73	26	account	account	NN
cord-028034-pjotppso	73	27	the	the	DT
cord-028034-pjotppso	73	28	delay	delay	NN
cord-028034-pjotppso	73	29	of	of	IN
cord-028034-pjotppso	73	30	virus	virus	NN
cord-028034-pjotppso	73	31	clearance	clearance	NN
cord-028034-pjotppso	73	32	.	.	.
cord-028034-pjotppso	74	1	This	this	DT
cord-028034-pjotppso	74	2	perspective	perspective	NN
cord-028034-pjotppso	74	3	focused	focus	VBD
cord-028034-pjotppso	74	4	on	on	IN
cord-028034-pjotppso	74	5	the	the	DT
cord-028034-pjotppso	74	6	aberration	aberration	NN
cord-028034-pjotppso	74	7	of	of	IN
cord-028034-pjotppso	74	8	neutrophil	neutrophil	NN
cord-028034-pjotppso	74	9	as	as	IN
cord-028034-pjotppso	74	10	one	one	CD
cord-028034-pjotppso	74	11	of	of	IN
cord-028034-pjotppso	74	12	the	the	DT
cord-028034-pjotppso	74	13	clinical	clinical	JJ
cord-028034-pjotppso	74	14	characteristics	characteristic	NNS
cord-028034-pjotppso	74	15	of	of	IN
cord-028034-pjotppso	74	16	COVID-19	COVID-19	NNP
cord-028034-pjotppso	74	17	.	.	NNP
cord-028034-pjotppso	74	18	1	1	CD
cord-028034-pjotppso	74	19	-	-	SYM
cord-028034-pjotppso	74	20	3	3	CD
cord-028034-pjotppso	75	1	Consequently	consequently	RB
cord-028034-pjotppso	75	2	,	,	,
cord-028034-pjotppso	75	3	the	the	DT
cord-028034-pjotppso	75	4	dose	dose	NN
cord-028034-pjotppso	75	5	ranges	range	NNS
cord-028034-pjotppso	75	6	of	of	IN
cord-028034-pjotppso	75	7	Vc	Vc	NNP
cord-028034-pjotppso	75	8	and	and	CC
cord-028034-pjotppso	75	9	Vd	Vd	NNP
cord-028034-pjotppso	75	10	among	among	IN
cord-028034-pjotppso	75	11	90	90	CD
cord-028034-pjotppso	75	12	-	-	SYM
cord-028034-pjotppso	75	13	1000	1000	CD
cord-028034-pjotppso	75	14	mg	mg	NN
cord-028034-pjotppso	75	15	and	and	CC
cord-028034-pjotppso	75	16	400	400	CD
cord-028034-pjotppso	75	17	-	-	SYM
cord-028034-pjotppso	75	18	1600	1600	CD
cord-028034-pjotppso	75	19	IU	IU	NNP
cord-028034-pjotppso	75	20	,	,	,
cord-028034-pjotppso	75	21	respectively	respectively	RB
cord-028034-pjotppso	75	22	,	,	,
cord-028034-pjotppso	75	23	might	may	MD
cord-028034-pjotppso	75	24	be	be	VB
cord-028034-pjotppso	75	25	enough	enough	JJ
cord-028034-pjotppso	75	26	and	and	CC
cord-028034-pjotppso	75	27	safe	safe	JJ
cord-028034-pjotppso	75	28	for	for	IN
cord-028034-pjotppso	75	29	the	the	DT
cord-028034-pjotppso	75	30	prevention	prevention	NN
cord-028034-pjotppso	75	31	or	or	CC
cord-028034-pjotppso	75	32	treatment	treatment	NN
cord-028034-pjotppso	75	33	of	of	IN
cord-028034-pjotppso	75	34	the	the	DT
cord-028034-pjotppso	75	35	cytokine	cytokine	NN
cord-028034-pjotppso	75	36	storm	storm	NN
cord-028034-pjotppso	75	37	caused	cause	VBN
cord-028034-pjotppso	75	38	by	by	IN
cord-028034-pjotppso	75	39	neutrophil	neutrophil	NN
cord-028034-pjotppso	75	40	,	,	,
cord-028034-pjotppso	75	41	whereas	whereas	IN
cord-028034-pjotppso	75	42	for	for	IN
cord-028034-pjotppso	75	43	the	the	DT
cord-028034-pjotppso	75	44	cases	case	NNS
cord-028034-pjotppso	75	45	not	not	RB
cord-028034-pjotppso	75	46	related	relate	VBN
cord-028034-pjotppso	75	47	to	to	IN
cord-028034-pjotppso	75	48	neutrophil	neutrophil	NN
cord-028034-pjotppso	75	49	,	,	,
cord-028034-pjotppso	75	50	high	high	JJ
cord-028034-pjotppso	75	51	dose	dose	NN
cord-028034-pjotppso	75	52	of	of	IN
cord-028034-pjotppso	75	53	Vc	Vc	NNP
cord-028034-pjotppso	75	54	or	or	CC
cord-028034-pjotppso	75	55	Vd	Vd	NNP
cord-028034-pjotppso	75	56	might	may	MD
cord-028034-pjotppso	75	57	be	be	VB
cord-028034-pjotppso	75	58	also	also	RB
cord-028034-pjotppso	75	59	helpful	helpful	JJ
cord-028034-pjotppso	75	60	for	for	IN
cord-028034-pjotppso	75	61	the	the	DT
cord-028034-pjotppso	75	62	treatment	treatment	NN
cord-028034-pjotppso	75	63	of	of	IN
cord-028034-pjotppso	75	64	COVID-19	covid-19	JJ
cord-028034-pjotppso	75	65	patients	patient	NNS
cord-028034-pjotppso	75	66	due	due	JJ
cord-028034-pjotppso	75	67	to	to	IN
cord-028034-pjotppso	75	68	the	the	DT
cord-028034-pjotppso	75	69	multifaceted	multifaceted	JJ
cord-028034-pjotppso	75	70	roles	role	NNS
cord-028034-pjotppso	75	71	of	of	IN
cord-028034-pjotppso	75	72	Vd	Vd	NNP
cord-028034-pjotppso	75	73	and	and	CC
cord-028034-pjotppso	75	74	Vc	Vc	NNP
cord-028034-pjotppso	75	75	.	.	NNP
cord-028034-pjotppso	75	76	9	9	CD
cord-028034-pjotppso	75	77	,	,	,
cord-028034-pjotppso	75	78	16	16	CD
cord-028034-pjotppso	75	79	,	,	,
cord-028034-pjotppso	75	80	18	18	CD
cord-028034-pjotppso	75	81	As	as	IN
cord-028034-pjotppso	75	82	the	the	DT
cord-028034-pjotppso	75	83	global	global	JJ
cord-028034-pjotppso	75	84	pandemic	pandemic	NN
cord-028034-pjotppso	75	85	is	be	VBZ
cord-028034-pjotppso	75	86	still	still	RB
cord-028034-pjotppso	75	87	growing	grow	VBG
cord-028034-pjotppso	75	88	,	,	,
cord-028034-pjotppso	75	89	if	if	IN
cord-028034-pjotppso	75	90	the	the	DT
cord-028034-pjotppso	75	91	vitamin	vitamin	NN
cord-028034-pjotppso	75	92	intervention	intervention	NN
cord-028034-pjotppso	75	93	for	for	IN
cord-028034-pjotppso	75	94	cytokine	cytokine	NN
cord-028034-pjotppso	75	95	storm	storm	NN
cord-028034-pjotppso	75	96	could	could	MD
cord-028034-pjotppso	75	97	be	be	VB
cord-028034-pjotppso	75	98	proved	prove	VBN
cord-028034-pjotppso	75	99	to	to	TO
cord-028034-pjotppso	75	100	be	be	VB
cord-028034-pjotppso	75	101	applicable	applicable	JJ
cord-028034-pjotppso	75	102	and	and	CC
cord-028034-pjotppso	75	103	efficient	efficient	JJ
cord-028034-pjotppso	75	104	,	,	,
cord-028034-pjotppso	75	105	it	-PRON-	PRP
cord-028034-pjotppso	75	106	would	would	MD
cord-028034-pjotppso	75	107	be	be	VB
cord-028034-pjotppso	75	108	tremendously	tremendously	RB
cord-028034-pjotppso	75	109	helpful	helpful	JJ
cord-028034-pjotppso	75	110	and	and	CC
cord-028034-pjotppso	75	111	easy	easy	JJ
cord-028034-pjotppso	75	112	to	to	TO
cord-028034-pjotppso	75	113	protect	protect	VB
cord-028034-pjotppso	75	114	the	the	DT
cord-028034-pjotppso	75	115	patients	patient	NNS
cord-028034-pjotppso	75	116	with	with	IN
cord-028034-pjotppso	75	117	COVID-19	COVID-19	,
cord-028034-pjotppso	75	118	worldwide	worldwide	RB
cord-028034-pjotppso	75	119	from	from	IN
cord-028034-pjotppso	75	120	the	the	DT
cord-028034-pjotppso	75	121	cytokine	cytokine	NN
cord-028034-pjotppso	75	122	storm	storm	NN
cord-028034-pjotppso	75	123	-	-	HYPH
cord-028034-pjotppso	75	124	related	relate	VBN
cord-028034-pjotppso	75	125	death	death	NN
cord-028034-pjotppso	75	126	.	.	.
cord-028034-pjotppso	76	1	Clinical	clinical	JJ
cord-028034-pjotppso	76	2	features	feature	NNS
cord-028034-pjotppso	76	3	of	of	IN
cord-028034-pjotppso	76	4	patients	patient	NNS
cord-028034-pjotppso	76	5	infected	infect	VBN
cord-028034-pjotppso	76	6	with	with	IN
cord-028034-pjotppso	76	7	2019	2019	CD
cord-028034-pjotppso	76	8	novel	novel	JJ
cord-028034-pjotppso	76	9	coronavirus	coronavirus	NN
cord-028034-pjotppso	76	10	in	in	IN
cord-028034-pjotppso	76	11	Wuhan	Wuhan	NNP
cord-028034-pjotppso	76	12	Clinical	clinical	JJ
cord-028034-pjotppso	76	13	characteristics	characteristic	NNS
cord-028034-pjotppso	76	14	of	of	IN
cord-028034-pjotppso	76	15	138	138	CD
cord-028034-pjotppso	76	16	hospitalized	hospitalize	VBN
cord-028034-pjotppso	76	17	patients	patient	NNS
cord-028034-pjotppso	76	18	with	with	IN
cord-028034-pjotppso	76	19	2019	2019	CD
cord-028034-pjotppso	76	20	novel	novel	JJ
cord-028034-pjotppso	76	21	coronavirus	coronavirus	NN
cord-028034-pjotppso	76	22	-	-	HYPH
cord-028034-pjotppso	76	23	infected	infect	VBN
cord-028034-pjotppso	76	24	pneumonia	pneumonia	NN
cord-028034-pjotppso	76	25	in	in	IN
cord-028034-pjotppso	76	26	Wuhan	Wuhan	NNP
cord-028034-pjotppso	76	27	Clinical	clinical	JJ
cord-028034-pjotppso	76	28	characteristics	characteristic	NNS
cord-028034-pjotppso	76	29	of	of	IN
cord-028034-pjotppso	76	30	coronavirus	coronavirus	NN
cord-028034-pjotppso	76	31	disease	disease	NN
cord-028034-pjotppso	76	32	2019	2019	CD
cord-028034-pjotppso	76	33	in	in	IN
cord-028034-pjotppso	76	34	China	China	NNP
cord-028034-pjotppso	77	1	Lymphopenia	Lymphopenia	NNP
cord-028034-pjotppso	77	2	predicts	predict	VBZ
cord-028034-pjotppso	77	3	disease	disease	NN
cord-028034-pjotppso	77	4	severity	severity	NN
cord-028034-pjotppso	77	5	of	of	IN
cord-028034-pjotppso	77	6	COVID-19	COVID-19	NNP
cord-028034-pjotppso	77	7	:	:	:
cord-028034-pjotppso	77	8	a	a	DT
cord-028034-pjotppso	77	9	descriptive	descriptive	JJ
cord-028034-pjotppso	77	10	and	and	CC
cord-028034-pjotppso	77	11	predictive	predictive	JJ
cord-028034-pjotppso	77	12	study	study	NN
cord-028034-pjotppso	77	13	Vitamin	vitamin	NN
cord-028034-pjotppso	77	14	C	c	NN
cord-028034-pjotppso	77	15	and	and	CC
cord-028034-pjotppso	77	16	immune	immune	JJ
cord-028034-pjotppso	77	17	function	function	NN
cord-028034-pjotppso	78	1	The	the	DT
cord-028034-pjotppso	78	2	Th17	Th17	NNP
cord-028034-pjotppso	78	3	pathway	pathway	NN
cord-028034-pjotppso	78	4	and	and	CC
cord-028034-pjotppso	78	5	inflammatory	inflammatory	JJ
cord-028034-pjotppso	78	6	diseases	disease	NNS
cord-028034-pjotppso	78	7	of	of	IN
cord-028034-pjotppso	78	8	the	the	DT
cord-028034-pjotppso	78	9	intestines	intestine	NNS
cord-028034-pjotppso	78	10	,	,	,
cord-028034-pjotppso	78	11	lungs	lung	NNS
cord-028034-pjotppso	78	12	and	and	CC
cord-028034-pjotppso	78	13	skin	skin	NN
cord-028034-pjotppso	78	14	Vitamin	vitamin	NN
cord-028034-pjotppso	78	15	D	d	NN
cord-028034-pjotppso	78	16	suppresses	suppress	VBZ
cord-028034-pjotppso	78	17	Th17	th17	CD
cord-028034-pjotppso	78	18	cytokine	cytokine	NN
cord-028034-pjotppso	78	19	production	production	NN
cord-028034-pjotppso	78	20	by	by	IN
cord-028034-pjotppso	78	21	inducing	induce	VBG
cord-028034-pjotppso	79	1	C	C	NNP
cord-028034-pjotppso	79	2	/	/	SYM
cord-028034-pjotppso	79	3	EBP	ebp	NN
cord-028034-pjotppso	79	4	homologous	homologous	JJ
cord-028034-pjotppso	79	5	protein	protein	NN
cord-028034-pjotppso	79	6	(	(	-LRB-
cord-028034-pjotppso	79	7	CHOP	CHOP	NNP
cord-028034-pjotppso	79	8	)	)	-RRB-
cord-028034-pjotppso	79	9	expression	expression	NN
cord-028034-pjotppso	80	1	Dietary	dietary	JJ
cord-028034-pjotppso	80	2	vitamin	vitamin	NN
cord-028034-pjotppso	80	3	D	d	NN
cord-028034-pjotppso	80	4	intake	intake	NN
cord-028034-pjotppso	80	5	for	for	IN
cord-028034-pjotppso	80	6	the	the	DT
cord-028034-pjotppso	80	7	elderly	elderly	JJ
cord-028034-pjotppso	80	8	population	population	NN
cord-028034-pjotppso	80	9	:	:	:
cord-028034-pjotppso	81	1	update	update	VB
cord-028034-pjotppso	81	2	on	on	IN
cord-028034-pjotppso	81	3	the	the	DT
cord-028034-pjotppso	81	4	Recommended	Recommended	NNP
cord-028034-pjotppso	81	5	Dietary	Dietary	NNP
cord-028034-pjotppso	81	6	Allowance	Allowance	NNP
cord-028034-pjotppso	81	7	(	(	-LRB-
cord-028034-pjotppso	81	8	RDA	RDA	NNP
cord-028034-pjotppso	81	9	)	)	-RRB-
cord-028034-pjotppso	81	10	for	for	IN
cord-028034-pjotppso	81	11	vitamin	vitamin	NN
cord-028034-pjotppso	81	12	D	d	NN
cord-028034-pjotppso	81	13	Evidence	evidence	NN
cord-028034-pjotppso	81	14	that	that	IN
cord-028034-pjotppso	81	15	vitamin	vitamin	NN
cord-028034-pjotppso	81	16	D	d	NN
cord-028034-pjotppso	81	17	supplementation	supplementation	NN
cord-028034-pjotppso	81	18	could	could	MD
cord-028034-pjotppso	81	19	reduce	reduce	VB
cord-028034-pjotppso	81	20	risk	risk	NN
cord-028034-pjotppso	81	21	of	of	IN
cord-028034-pjotppso	81	22	influenza	influenza	NN
cord-028034-pjotppso	81	23	and	and	CC
cord-028034-pjotppso	81	24	COVID-19	covid-19	JJ
cord-028034-pjotppso	81	25	infections	infection	NNS
cord-028034-pjotppso	81	26	and	and	CC
cord-028034-pjotppso	81	27	deaths	death	NNS
cord-028034-pjotppso	82	1	Backman	Backman	NNP
cord-028034-pjotppso	82	2	V.	V.	NNP
cord-028034-pjotppso	83	1	The	the	DT
cord-028034-pjotppso	83	2	role	role	NN
cord-028034-pjotppso	83	3	of	of	IN
cord-028034-pjotppso	83	4	vitamin	vitamin	NN
cord-028034-pjotppso	83	5	D	d	NN
cord-028034-pjotppso	83	6	in	in	IN
cord-028034-pjotppso	83	7	suppressing	suppress	VBG
cord-028034-pjotppso	83	8	cytokine	cytokine	JJ
cord-028034-pjotppso	83	9	storm	storm	NN
cord-028034-pjotppso	83	10	in	in	IN
cord-028034-pjotppso	83	11	COVID-19	covid-19	JJ
cord-028034-pjotppso	83	12	patients	patient	NNS
cord-028034-pjotppso	83	13	and	and	CC
cord-028034-pjotppso	83	14	associated	associate	VBD
cord-028034-pjotppso	83	15	mortality	mortality	NN
cord-028034-pjotppso	83	16	Inhibition	inhibition	NN
cord-028034-pjotppso	83	17	of	of	IN
cord-028034-pjotppso	83	18	tumor	tumor	NN
cord-028034-pjotppso	83	19	cell	cell	NN
cord-028034-pjotppso	83	20	growth	growth	NN
cord-028034-pjotppso	83	21	by	by	IN
cord-028034-pjotppso	83	22	interferongamma	interferongamma	NNP
cord-028034-pjotppso	83	23	is	be	VBZ
cord-028034-pjotppso	83	24	mediated	mediate	VBN
cord-028034-pjotppso	83	25	by	by	IN
cord-028034-pjotppso	83	26	two	two	CD
cord-028034-pjotppso	83	27	distinct	distinct	JJ
cord-028034-pjotppso	83	28	mechanisms	mechanism	NNS
cord-028034-pjotppso	83	29	dependent	dependent	JJ
cord-028034-pjotppso	83	30	upon	upon	IN
cord-028034-pjotppso	83	31	oxygen	oxygen	NN
cord-028034-pjotppso	83	32	tension	tension	NN
cord-028034-pjotppso	83	33	:	:	:
cord-028034-pjotppso	83	34	induction	induction	NN
cord-028034-pjotppso	83	35	of	of	IN
cord-028034-pjotppso	83	36	tryptophan	tryptophan	NN
cord-028034-pjotppso	83	37	degradation	degradation	NN
cord-028034-pjotppso	83	38	and	and	CC
cord-028034-pjotppso	83	39	depletion	depletion	NN
cord-028034-pjotppso	83	40	of	of	IN
cord-028034-pjotppso	83	41	intracellular	intracellular	JJ
cord-028034-pjotppso	83	42	nicotinamide	nicotinamide	NN
cord-028034-pjotppso	83	43	adenine	adenine	NN
cord-028034-pjotppso	83	44	dinucleotide	dinucleotide	NN
cord-028034-pjotppso	84	1	A	a	DT
cord-028034-pjotppso	84	2	new	new	JJ
cord-028034-pjotppso	84	3	recommended	recommend	VBN
cord-028034-pjotppso	84	4	dietary	dietary	JJ
cord-028034-pjotppso	84	5	allowance	allowance	NN
cord-028034-pjotppso	84	6	of	of	IN
cord-028034-pjotppso	84	7	vitamin	vitamin	NN
cord-028034-pjotppso	84	8	C	c	NN
cord-028034-pjotppso	84	9	for	for	IN
cord-028034-pjotppso	84	10	healthy	healthy	JJ
cord-028034-pjotppso	84	11	young	young	JJ
cord-028034-pjotppso	84	12	women	woman	NNS
cord-028034-pjotppso	84	13	Vitamin	vitamin	NN
cord-028034-pjotppso	84	14	C	c	NN
cord-028034-pjotppso	84	15	pharmacokinetics	pharmacokinetic	NNS
cord-028034-pjotppso	84	16	in	in	IN
cord-028034-pjotppso	84	17	healthy	healthy	JJ
cord-028034-pjotppso	84	18	volunteers	volunteer	NNS
cord-028034-pjotppso	84	19	:	:	:
cord-028034-pjotppso	84	20	evidence	evidence	NN
cord-028034-pjotppso	84	21	for	for	IN
cord-028034-pjotppso	84	22	a	a	DT
cord-028034-pjotppso	84	23	recommended	recommend	VBN
cord-028034-pjotppso	84	24	dietary	dietary	JJ
cord-028034-pjotppso	84	25	allowance	allowance	NN
cord-028034-pjotppso	85	1	An	an	DT
cord-028034-pjotppso	85	2	anti	anti	JJ
cord-028034-pjotppso	85	3	-	-	JJ
cord-028034-pjotppso	85	4	oxidative	oxidative	JJ
cord-028034-pjotppso	85	5	therapy	therapy	NN
cord-028034-pjotppso	85	6	for	for	IN
cord-028034-pjotppso	85	7	ameliorating	ameliorate	VBG
cord-028034-pjotppso	85	8	cardiac	cardiac	JJ
cord-028034-pjotppso	85	9	injuries	injury	NNS
cord-028034-pjotppso	85	10	of	of	IN
cord-028034-pjotppso	85	11	critically	critically	RB
cord-028034-pjotppso	85	12	ill	ill	JJ
cord-028034-pjotppso	85	13	COVID-19	COVID-19	NNP
cord-028034-pjotppso	85	14	Rheumatologists	Rheumatologists	NNPS
cord-028034-pjotppso	85	15	'	'	POS
cord-028034-pjotppso	85	16	perspective	perspective	NN
cord-028034-pjotppso	85	17	on	on	IN
cord-028034-pjotppso	85	18	coronavirus	coronavirus	NN
cord-028034-pjotppso	85	19	disease	disease	NN
cord-028034-pjotppso	85	20	19	19	CD
cord-028034-pjotppso	85	21	(	(	-LRB-
cord-028034-pjotppso	85	22	COVID-19	COVID-19	NNP
cord-028034-pjotppso	85	23	)	)	-RRB-
cord-028034-pjotppso	85	24	and	and	CC
cord-028034-pjotppso	85	25	potential	potential	JJ
cord-028034-pjotppso	85	26	therapeutic	therapeutic	JJ
cord-028034-pjotppso	85	27	targets	target	NNS
cord-028034-pjotppso	86	1	Can	Can	MD
cord-028034-pjotppso	86	2	early	early	JJ
cord-028034-pjotppso	86	3	and	and	CC
cord-028034-pjotppso	86	4	high	high	JJ
cord-028034-pjotppso	86	5	intravenous	intravenous	JJ
cord-028034-pjotppso	86	6	dose	dose	NN
cord-028034-pjotppso	86	7	of	of	IN
cord-028034-pjotppso	86	8	vitamin	vitamin	NN
cord-028034-pjotppso	86	9	C	c	NN
cord-028034-pjotppso	86	10	prevent	prevent	VBP
cord-028034-pjotppso	86	11	and	and	CC
cord-028034-pjotppso	86	12	treat	treat	VBP
cord-028034-pjotppso	86	13	coronavirus	coronavirus	NN
cord-028034-pjotppso	86	14	disease	disease	NN
cord-028034-pjotppso	86	15	2019	2019	CD
cord-028034-pjotppso	86	16	(	(	-LRB-
cord-028034-pjotppso	86	17	COVID-19	COVID-19	NNP
cord-028034-pjotppso	86	18	Shanghai	Shanghai	NNP
cord-028034-pjotppso	86	19	Clinical	Clinical	NNP
cord-028034-pjotppso	86	20	Treatment	Treatment	NNP
cord-028034-pjotppso	86	21	Expert	Expert	NNP
cord-028034-pjotppso	86	22	Group	Group	NNP
cord-028034-pjotppso	86	23	for	for	IN
cord-028034-pjotppso	86	24	corona	corona	NNP
cord-028034-pjotppso	86	25	virus	virus	NN
cord-028034-pjotppso	86	26	disease	disease	NNP
cord-028034-pjotppso	86	27	2019	2019	CD
cord-028034-pjotppso	86	28	.	.	.
cord-028034-pjotppso	87	1	Comprehensive	comprehensive	JJ
cord-028034-pjotppso	87	2	treatment	treatment	NN
cord-028034-pjotppso	87	3	and	and	CC
cord-028034-pjotppso	87	4	management	management	NN
cord-028034-pjotppso	87	5	of	of	IN
cord-028034-pjotppso	87	6	corona	corona	NNP
cord-028034-pjotppso	87	7	virus	virus	NN
cord-028034-pjotppso	87	8	disease	disease	NNP
cord-028034-pjotppso	87	9	2019	2019	CD
cord-028034-pjotppso	87	10	:	:	:
cord-028034-pjotppso	87	11	expert	expert	JJ
cord-028034-pjotppso	87	12	consensus	consensus	NN
cord-028034-pjotppso	87	13	statement	statement	NN
cord-028034-pjotppso	87	14	from	from	IN
cord-028034-pjotppso	87	15	Shanghai	Shanghai	NNP
cord-028034-pjotppso	87	16	High	High	NNP
cord-028034-pjotppso	87	17	-	-	HYPH
cord-028034-pjotppso	87	18	dose	dose	NN
cord-028034-pjotppso	87	19	intravenous	intravenous	JJ
cord-028034-pjotppso	87	20	vitamin	vitamin	NN
cord-028034-pjotppso	87	21	C	c	NN
cord-028034-pjotppso	87	22	treatment	treatment	NN
cord-028034-pjotppso	87	23	for	for	IN
cord-028034-pjotppso	87	24	COVID-19	COVID-19	NNP
cord-028034-pjotppso	88	1	The	the	DT
cord-028034-pjotppso	88	2	author	author	NN
cord-028034-pjotppso	88	3	declares	declare	VBZ
cord-028034-pjotppso	88	4	no	no	DT
cord-028034-pjotppso	88	5	conflict	conflict	NN
cord-028034-pjotppso	88	6	of	of	IN
cord-028034-pjotppso	88	7	interest	interest	NN
cord-028034-pjotppso	88	8	.	.	.
cord-028034-pjotppso	88	9	 	 	_SP